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ABSTRACT 
Metabolic engineering has evolved to the point of fulfilling the dream of having industrial 
chemicals produced renewably. Carboxylic acids [e.g., short chain fatty acids (SCFAs) such 
as octanoic acid (C8)] are such chemical intermediates that can be produced by Escherichia 
coli engineered with thioesterases specific for short chain fatty acids. However, C8 is toxic to 
E. coli at concentration greater than 10 mM. To design a better host strain for the production 
of large amount of SCFAs, 
13
C metabolic flux analysis of E. coli was performed for both C8 
stress and control condition (without C8). To investigate central carbon metabolism for the 
culture environmental change, a mixture of labeled and unlabeled glucose was used as the 
sole carbon source for bacterial growth and proteinogenic amino acid isotopomers were 
measured using two-dimensional (
13
C, 
1
H) HSQC NMR spectroscopy. Notable differences of 
several amino acids isotopomer abundance were observed between the control condition and 
C8 stress condition, suggesting that the precursor nodes of these amino acids in metabolic 
pathways were responding to the stress. More specifically, the difference suggested that the 
distribution of fluxes among the tricarboxylic acid (TCA) cycle, pentose phosphate pathway, 
pyruvate node, α-ketoglutarate node and oxaloacetate node changed. By comparing the 
metabolic flux maps of E. coli MG1655 grown at different conditions, pathways that have 
flux change under stress were identified. Inhibition effect for several pathways, resulting in a 
reduction in carbon flux, was found under stress: the TCA cycle flux by ~ 44%; the malic 
enzyme pathway by ~ 80%; the phosphoenolpyruvate carboxylase pathway ~ 60%; the CO2 
production rate by 18%; and pyruvate dehydrogenase pathway by ~50%. Meanwhile, a few 
pathways were activated under C8 stress: the pyruvate dehydrogenase flux (‘PoxB’) became 
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active; the malate dehydrogenase pathway (‘mdh’) in TCA cycle increased by ~55%; and the 
extracellular acetate production increased by ~ 80%. Based on these results, a hypothesis 
was proposed that low activity of NADH dehydrogenase may lead to low ratio of 
NAD
+
/NADH which in turn causes the low activity of two major pathways (TCA cycle, and 
pyruvate dehydrogenase). The inefficiency of regeneration of NAD
+
 from NADH may occur 
when the cell membrane is disrupted, which has been proven by membrane fluidity study (L. 
Royce, L. Jarboe, unpublished data) as well as transcriptome (L. Royce, L. Jarboe, 
unpublished data) and proteomic (M Rodriquez, R. Gonzalez, unpublished data) data. 
Besides, the other reason for low ratio of NAD
+
/NADH is that the electron transport chain 
may be disrupted under stress. It is also possible that the PdhR (pyruvate dehydrogenase 
complex regulator) is activated by low concentration of intracellular pyruvate, which in turn 
represses ndh and cyoABCDE that encode two major enzymes in the electron transport chain.  
This hypothesis is supported by the observation that supplementation of additional pyruvate 
in the media helps the cell partially recover from the stress.
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CHAPTER 1 INTRODUCTION 
1.1 Motivation about toxicity study of C8 to Escherichia coli using 
metabolic flux analysis 
Switching from petrochemical feedstocks to biorenewable feedstocks is one of the major 
approaches to smooth the depletion of crude oil and environmental concerns, which leads to 
less dependence of petrochemicals and more diversity of feedstock. Short chain fatty acids 
(SCFAs) are one of the valuable intermediates, which could be produced from biorenewable 
feedstocks. SCFAs can be further catalyzed to -olefins and then polymerized to polyolefin. 
Metabolic engineering approaches are employed to rationally design cells for efficient 
production of fatty acids. Escherichia coli is one of the major workhorses in industrial 
fermentations since it has a simple and well-known whole genome sequence, which makes it 
an ideal candidate for gene manipulation [1]. Unfortunately, short chain fatty acids are toxic 
to Escherichia coli cell growth. Experimental data show that when the octanoic acid 
concentration reaches certain level, it will inhibit the bacterial cell growth. One of the most 
interesting questions is how the biological system responds when exposed to a higher toxic 
level. With the wish to commercialize the biological process into industrial scale, the 
economic beneficial number for the titer of short chain fatty acid production is larger than 5 
g/L, which is around 35 mM. When the cell is exposed to this level of C8, it shows dramatic 
growth inhibition. This paper will mainly focus on investigating the cell behavior when 
exposed to 35 mM C8 by quantification of in vivo enzymatic reaction rates or fluxes. 
Metabolic flux analysis plays an important role in metabolic engineering cycle. First of all, 
when integrated with transcriptomics and proteomics analysis, the physiological state of the 
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cell can be systematically described in three different levels of biological information. Based 
on these results, rational gene modification strategies could be proposed for improving stain 
performance with high tolerance to C8 stress. Secondly, metabolic flux analysis provides 
detailed description about the change in central carbon metabolic pathways under certain 
culture environment stress or gene modifications[2]. A reliable central carbon metabolism 
pathway map is the major outcome, which additionally can be used to provide constraints for 
genome-scale models for prediction of cellular metabolic changes under different conditions 
by using constraints-based reconstruction and analysis (COBRA) [3]. 
1.2 The role of metabolic flux analysis in metabolic engineering 
Metabolic engineering has been defined as ‘the directed improvement of product formation 
or cellular properties through the modification of specific biochemical reaction(s) or the 
introduction of new one(s) with the use of recombination DNA technology’[2]. Metabolic 
engineering provides a valuable platform for integration biological information in order to 
develop biological processes for production of valuable chemicals [2]. Every biological 
system has a hierarchical structure information from genomics, transcriptomics, proteomics, 
metabolomics and fluxomics, as shown in Figure 1[4].  
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Figure 1 Illustration of different levels of information in the cell[4] 
Among these different levels of information, fluxomics is the probe of the integration effect 
for different levels of biological regulation. Metabolic flux, which is defined as the 
intracellular enzymatic reaction rate, is the outcome of the nonlinear relation between 
genomics, transcriptomics, and proteomics. Integration of different levels of biological 
information will help to clarify metabolic regulation which is illustrated in Figure 2[4].   
Figure 2 Integration of different levels of information for clarification of metabolic regulation[4]
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Due to the small pool size of the intracellular metabolites and the difference between in vitro 
enzyme activities, experimental measurements of the in vivo enzyme activities is difficult. An 
alternative approach (
13
C labeling metabolic flux analysis) for determination in vivo reaction 
rate (metabolic flux) has been developed using computer-based models with interpretation of 
the isotopic steady state labeling pattern of the intracellular metabolites[5]. 
1.3 Overview and current status of 
13
C labeling metabolic flux analysis 
The underlying principle for metabolic flux analysis is the mass balance of the intracellular 
key metabolites[4]. Two major approaches are available for elucidation of metabolic pathway 
fluxes. One is conventional flux analysis, which uses measured extracellular and biomass 
fluxes (such as substrate uptake rate, production secret rate, and biomass composition 
profiling) with the stoichiometric constraints from mass balances for a determined system - 
while quick, determined networks rarely capture actual network functioning in real biological 
systems. In case of the underdetermined systems, additional constraints are needed in order 
to make the system solvable. In most cases, the constraints include the cofactor balance, or an 
objective function, which usually will be biomass flux maximization or cofactor 
optimization. The results will be less reliable and accurate as they are largely dependent on 
the assumptions not experimental data[2]. Another approach, 
13
C carbon based flux analysis, 
has been developed for addressing these pitfalls by obtaining intracellular information, i.e. 
measuring the proteinogenic amino acids isotopomer fraction to solve the mathematical 
construction for the biological system [4]. The typical 
13
C carbon labeling experiment is 
illustrated in Figure 3[4].   
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Figure 3 The experimental paradigm of 13C based flux analysis[4] 
13
C carbon based flux analysis is more complicated but powerful than conventional flux 
analysis. The proteinogenic amino acid isotopomer labeling pattern is measured, which 
reflects the labeling pattern of their precursors in the central carbon metabolism. The 
nonlinear nature between isotopomer labeling pattern and the intracellular flux makes the 
mathematic problem much more complicated. But it has the power to solve the parallel 
reactions, bidirectional reactions as well as the cycle flux[2]. Additionally, the quality of the 
fitting can be one of the criteria for assessing the accuracy of the proposed metabolic network 
topology, and sometimes can be used for discovering new pathways. 
Currently, the following perspectives of 
13
C labeling metabolic flux analysis are under 
intensive improvement [3, 4, 6-10]:  
1) Extend the scope of metabolic flux analysis from steady state systems to dynamic 
systems by mainly two ways: 
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a. Combining the key ideas from isotopomer spectral analysis and stationary 
MFA by using elementary metabolite units method for flux determination[4, 
8, 9, 11] 
b.  Measuring the mass isotopomer distribution of intracellular metabolites using 
different measurements [4, 6]. 
2) Construct the large scale metabolic pathway model 
a. Combination of constraint-based modeling framework with isotopic label 
tracing on a large scale [3, 10, 12] 
b. Construction genome-scale atom mapping model for MFA calculations 
enables the complete tracking of labeled atoms through pathways [4, 7]. 
In this study, three major outcomes of metabolic flux analysis of E. coli under C8 stress have 
been presented. First, the metabolic pathways that are affected under C8 stress have been 
identified. Second, a hypothesis for explanation of toxicity mechanism for C8 stress has been 
proposed. Finally, strategies for improving the tolerance of E. coli to C8 are suggested. 
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CHAPTER 2 LITERATURE REVIEW 
Metabolic flux analysis can be used for analyzing the relation between phenotype and 
genotype by quantifying the integration system response for gene-protein-metabolites 
interactions [2, 5, 12].  With deciphering the relation, the biological system can be modeled 
and predicted the cell behavior after gene manipulation under certain growth condition [3, 
12-14]. This Chapter will be mainly focusing on reviewing fundamental principle in 
metabolic flux analysis, the major contribution of metabolic flux analysis and the recent 
research work for improving metabolic flux analysis for better performance in terms of 
efficiency and accuracy. 
2.1 Overview about metabolic flux analysis  
Metabolic flux analysis quantitatively depicts the systematic response to perturbations from 
gene modification or growth condition changes [2, 15]. 
13
C flux analysis is the most powerful 
tool in metabolic flux analysis [4, 5]. By measuring the proteinogenic amino acids or 
intracellular metabolite isotopomer pattern, in vivo flux can be determined without 
decoupling the interaction among genome, proteins and metabolites. 
13
C flux analysis has 
been used for microbes [5, 6, 11, 16-19], plants[5, 20], and higher organisms under various 
conditions[5, 21]. 
2.1.1 Metabolic flux balance analysis  
The underlying principle of metabolic flux balance analysis is applying the mass balance 
equations for each metabolite in the network with the assumption of steady state [2, 14, 22]. 
By doing simple matrix calculation, a unique solution can be obtained when the system is 
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determined or over-determined. For underdetermined systems, there are two major 
approaches. One is obtaining extra information, i.e. the intracellular information such as 
isotopomer distribution for intracellular metabolites or proteinogenic amino acids. This 
method has been developed into 
13
C based flux analysis. The other way is to using certain 
objective function to optimize the system [3, 6, 14, 22]. With the availability of annotated 
genome sequence for microbes, genome-scale reaction network reconstruction becomes 
possible. The constraint-based reconstruction and analysis (COBRA) approach is under 
development mainly for generation of hypotheses for certain condition and prediction of cell 
behavior under certain gene-modifications [13].  
2.1.2 
13
C based flux analysis 
The typical procedure of 
13
C based flux analysis is using labeling tracers as the substrate for 
cell growth. During cell growth, the label information will be distributed among the 
metabolic pathways.  For stationary metabolic flux analysis, the labeling patterns are 
measured from 10-15 proteinogenic amino acids [23-26] after the isotopic steady state has 
been achieved. Protein is a stable and relative abundant source of labeling information in the 
cell, and the carbon backbone of eight key intermediates are conserved in amino acids [23]. 
Computer-aided modeling is needed to solve the system with both mass balances and 
isotopomer balances. Several programs have been developed for 
13
C based flux analysis, 
such as FiatFlux [19, 27] for flux ratio determination, 13CFLUX [15, 28-32], and NMR2Flux 
[20]. 
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2.2 Nonstationary 
13
C metabolic flux analysis (MFA)  
Two major needs leading led into the necessity of developing the dynamic 
13
C metabolic flux 
analysis. One is the batch fermentation which is widely used in industry has the nature of 
non-stationary. The second reason is that most of the target chemicals produced in the 
stationary phase, which leads to the needs for deep insight about metabolic flux alternation 
with time dependent. In order to fulfill the needs of dynamic flux analysis, the classical 
13
C 
flux analysis can be refined both in computation method [33] and experimental approaches 
[6, 11]. 
Wiechert develop an extension of the 13CFLUX software toolkit to implement the simulation 
of instationary isotopomer carbon labeling experiment during metabolic steady state phase, 
sensitivity calculation with respect to unknown parameters, fitting the model to the measured 
data, statistical identifiability analysis and optimal experimental design [33]. 
For improvement in experimental approaches, the most significant effort is try to measure the 
isotopic pattern for intracellular metabolites by CE-TOF-MS [6, 34], GC/MS-MALDI/TOF 
MS[35], and LC-MS/MS[36] or LC-MS [37] instead of proteinogenic amino aicds. As the 
small pool size of the intracellular metabolites, the metabolic flux response is much faster 
than proteingenic amino acids, which dramatically shorten the experimental time. 
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CHAPTER 3 MATERIALS AND METHODS 
3.1 Strain, inoculum screening method, and culture conditions 
Escherichia coli MG1655 wild type has been used in this work to investigate the toxicity 
effect of octanoic acid (C8) under aerobic conditions.  In order to screen the active inoculum 
for bioreactor operation, the following screening procedure has been conducted. The strain 
from -80°C frozen stock was streaked on normal LB plates, and incubated at 37 °C for 12 
hours. One single colony from the plates was used to inoculate into 250ml flask with 25ml 
defined media (MOPs media or M9 media, the detailed composition of these two media 
attached in the Appendix) supplemented with 10 g/l of glucose, and incubated at 37 °C air 
bath shaker until mid-log phase (OD550 reaches around 0.5 to 1.0), and then inoculated into 
sub-culture flask with fresh media to maintain the active growing cell state, and ensure the 
same age until the OD550 reaches close to 1.0.  The amount of sub-culture needed was 
centrifuged at 4000 rpm for 15 min at +4°C, the supernatant were discarded, and the pellet 
was re-suspended in fresh media twice. Repeat the process twice to get rid of the 
extracellular metabolites residue. The washed pellet was reconstituted in the fresh media, and 
inoculated into 400ml media in the bioreactor with the start targeting OD550 around 0.03 
±0.01. 
In order to prevent foaming, 500ul of 50% volume concentration of antifoam solution 
(Antifoam B Silicone Emulsion, J.T. Baker) was added into the 400 ml media. The aerobic 
fermentation was conducted at 37 °C in 500ml bioreactor (Multifor system) with a gas flow 
rate at 0.6 ml/min with 400 ml of media. The pH was controlled at 7.0±0.05 by 1M 
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potassium hydroxide (KOH) and the stir speed was set at 600rpm. The dissolved oxygen 
level was maintained above 50% of saturated levels to ensure aerobic conditions.  
3.2 Dry weight biomass measurement and extracellular metabolite 
measurements 
Cell biomass dry weight was determined by measuring optical density OD550 using a 
spectrophotometer (Genesys 20, Thermospectronic and Madison, Wisconsin). Then 
correlated dry weight with OD550 according to the relation ‘1 OD550 =0.36g DW/L’ basing on 
literature [38]. Biomass composition was also determined from the literature data[39] , and 
attached in the Appendix. 
Media samples were first filtered through 0.2 μm syringe filter (x pertek, syringe filter, 
13mm, 0.2 μm, nylon, P.J. Cobert Associates) then measured on Waters (Milford, MA) 
HPLC system with a 410 refractive index (RI) detector for glucose and fermentation products 
measurement. Different setting of the HPLC was used for different media conditions. For M9 
minimal media, the Aminex column (HPX-87H, Bio-Rad, Hercules, CA, USA) was set at 
room temperature; 5 mM sulfuric acid has been used as the mobile phase at the flow rate of 
0.3 ml/min. For analyzing samples in MOPs media, the column temperature has been set at 
45 °C, and 30 mM sulfuric acid has been used as the mobile phase.  
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3.2 Calculation of biomass yield, products yield and specific rate for the 
cells under exponential phase. 
The batch fermentation has a nature of dynamic condition. An assumption has been made 
during cell exponential phase, a pseudo-metabolic-steady-state assumption [2, 40], which 
means in the active cell growth period, the cell functions at steady state. The substrate uptake 
rate is constant during exponential phase, and the fermentation product rates are constant as 
well. The substrate uptake rate is defined as
 
 
  
  
, in which S represents the substrate 
concentration, X is the biomass concentration. It can be rewritten as
  
  
 
 
 
  
  
, which is equal 
to 
  
  
  . Yield biomass is defined as 
  
  
, should be a constant during exponential phase as well. 
  
  
 can be interpreted as the slope of X~S plot during exponential phase. Biomass 
concentration versus substrate concentration is a straight line during the cell exponential 
growth phase. Yield biomass  can be obtained from linear regression between X (biomass 
concentration) and S (substrate concentration which is glucose) at each time point. The 
metabolite production yield is constant as well, which can be interpreted as the slope of the 
plot P versus S (production concentration versus substrate concentration). The detailed 
example calculation for biomass yield, metabolite product yield, specific uptake rate and 
metabolite production rate are attached in Appendix.   
3.3 
13
C carbon labeling experiment 
Batch fermentations were conducted for studying the toxicity effect of octanoic acid to E. 
coli MG1655 under aerobic conditions. For better identification [6, 16, 31] , a mixture of 
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uniformly labeled [U-
13
C], first carbon labeled [1-
13
C] and natural glucose was used for 
13
C 
flux analysis. Specifically, 25% U-
13
C glucose, 25% 1-
13
C glucose, and 50% of naturally 
labeled glucose was used as the tracer in this study. The biomass has been harvested at the 
OD550 =1.50±0.10  in the middle log phase, which ensures enough time (longer than 5 
doubling time) for reaching the isotopic steady state at metabolic steady state.  
For measuring the proteinogenic acid isotopomers, GC-MS and 2D (
1
H,
13
C) Heteronuclear 
single quantum coherence (HSQC) NMR have been used. The following section will 
describe the detailed sample preparation process for NMR and GC-MS respectively. 
3.3.1 Sample preparation and isotopomer measurement of proteinogenic 
amino acids for GC-MS analysis[15] 
Around 0.8 gram to 1.0 gram of dry weight biomass has been used for GCMS analysis. The 
biomass has been spun down at 4000 rpm at +4°C, and the pellet has been washed by 0.9% 
NaCl (sodium chloride). 200μL of HCL (Hydrochloride acid) was added into the sample and 
hydrolysis at 105 °C for 12 hours to 18 hours. The sample has been dried at 95°C with the 
airflow which accelerated the drying process. The dried sample is reconstituted in nano pure 
water. The sample was added 20 μL N-(tert-butyldimethylsilyl)-N-methyl-trifluroacetamide 
(TBMS) (derivatization grade, Aldrich, St. Louis, Mo.) and dimethylformamide (DMF) 
(Sigma, St. Louis), and was derivatized for 1 to 2 hrs. The protocol for GC-MS sample has 
been attached in the Appendix. 
GC-MS analysis was carried out using an Agilent 5973C Series GC/MSD (Agilent) equipped 
with a HP-5 column (30 m×0.25 mm×0.50 μm, Agilent). An injection volume of 1 μL was 
used, with the flow model in split control. The carrier gas flow rate was set at 1 mL/min. The 
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oven temperature was initially held at 100°C for 5 min. Following this step, the temperature 
was raised at a rate of 10°C /min until the temperature reached 250°C. The final temperature 
was maintained for 12 min.  
The mass fragment data can be extracted by GCMS data analysis software from the mass 
spectrum for each amino acid manually. A total of 15 of the 20 amino acids were detected in 
the sample; cysteine and tryptophan were lost due to oxidation, glutamate, asparagine were 
deamidated to glutamate and aspartate respectively, and the less stable histidine derivative 
was not detected, due to the degradation[41]. Those amino acids fragments with good 
measurement accuracy (maximum difference between measured and theoretical abundances 
for natural amino acids <0.4%) has been accepted for 
13
C flux analysis according to previous 
work [40]. 
3.3.2 Sample preparation and isotopomer measurement of proteinogenic 
amino acids for 2D (
1
H,
13
C) Heteronuclear single quantum coherence 
(HSQC) NMR analysis 
The biomass has been harvested at the OD550 of 1.5±0.1 ((longer than 5 doubling time) to 
ensure the isotopical steady state and the cell growth was quenched by swirling in the dry ice 
ethanol bath for 40 seconds, and kept on the ice water bath. The cells were centrifuged at 
4000g for 30 minutes at 4°C afterwards. The pellet were washed with nano-pure water and 
centrifuged again for 30 minutes at 4000g and then stored in -80°C freezer. The cell pellets 
(around 96 mg of biomass) were thawed and added with 6N constant-boiling point of HCL 
(hydrochloric acid) at the ratio of 1 ml of HCL: 4mg HCL, and transferred into four 
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hydrolysis tubes (Pierce Endogen, Rockford, IL). The hydrolysis tubes were purged with 
nitrogen and vacuumed for three times to get rid of the residue oxygen. The hydrolysis was 
performed at 105 °C for 12-18 hours. The residue HCL in hydrolysate was evaporated using 
Rapidvap evaporator (Labconco, Kansan City, MO) under vacuum for 3 hours at 45°C. The 
dry hydrolysis residue was reconstituted by adding 2ml of nano-pure water and filtered with 
centrifuge filter tubes at 5000g for 5minutes to get rid of biomass ash. The samples were 
frozen to -80 °C and lyophilized for in freezer-dry system (Lanconco Corp., Kansas City, 
MO). The dried sampled was dissolved in 600 μL of D2O (Sigma,St.Louis) in NMR tube for 
isotopic pattern measurement.. 
Two-dimensional [
13
C, 
1
H] HSQC NMR spectra were collected on a Bruker Advance DRX 
500 MHz spectrometer (Bruker Instruments, Billerica, MA) at 298K, which is similar to Dr. 
Shanks group’s previous work[42]. The reference to 0 ppm was set using methyl signal of 
trimethylsilyl-1-propanesulfonic acid, sodium salt (Aldrich, Sigma, St. Louis) as an internal 
standard. The resonance frequencies of 
13
C, 
1
H were 125.7 MHZ and 499.99MHZ, 
respectively. The spectral width was 5482.26 Hz along the 
1
H (F2) dimension and 5028.05 
Hz along the 
13
C (F1) dimension. Peak aliasing was used in order to minimize the sweep 
width along the F1 dimension. The number of complex data points was 1,024 (
1
H) × 900 
(
13
C). A modification of the INEPT (intensive nuclei enhanced by polarization transfer) pulse 
sequence was used for acquiring HSQC spectra. The number of scans was generally set to 
16. 
The software Xwinnmr (Bruker Instruments, Bi llerica, MA) was used for obtain all spectra, 
the software NMR Viewer was used to quantify the non-overlapping multiplets on the HSQC 
spectrum. Overlapping multiplets (α-amino acid), which could not be processed with 
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NMRViewer, were quantified by peak de-convolution software based on spectral processing 
algorithm proposed by Van Winden et al [42]. 
3.3 Fatty acid extraction and analysis and quantification using GCMS. 
The temporal profile of fatty acids in the media was measured in order to ascertain whether 
or not the cell took up fatty acids from the media. The concentration of the fatty acid in the 
media was measured by the direct injection (free fatty acid in media without derivatization) 
method in GC-MS. Sample preparation for direct injection has been attached in the 
Appendix7.2.  500 μL of media sample from the supernatant has added into the tube, then 
500ul of 0.5 N HCL (hydrochloride acid) was added to acidify the sample.  An internal 
standard, heptanoic acid (C7) was used. A 2ml mixture solution of chloroform: methanol 
(with volume ratio 1:1) was added into the sample and vortexed for 10 minutes. The sample 
was centrifuged at 4000g for 15 minutes. The lower layer of the chloroform layer was 
transferred into clean tubes, then the sample dried using N2, and finally then dissolved into 
chloroform to the desired concentration for injection into the GCMS to analysis fatty acid 
concentration. 
3.4 Mathematical modeling of the reaction network 
The Shanks lab has developed NMR2Flux for mathematically modeling of the reaction 
network [20]. The NMR2Flux  includes a singular value decomposition method to guess an 
initial set of fluxes. These fluxes are converted to isotopomer distributions using a Boolean 
function mapping method. The simulated and experimental (from NMR data) distributions 
are compared and the error between them is minimized using simulated annealing. The fluxes 
are refined using the Monte Carlo method and the process is repeated until the global 
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optimum is found. The program estimates a new set of initial fluxes and multiple simulations 
can be carried out. The package also includes statistical analysis of the results and provides 
90% confidence intervals for the fluxes and reversibility.  
A metabolic model need be proposed basing on existing biological knowledge before running 
NMR2Flux. The known fluxes such as biomass fluxes, which can be determined by 
measuring the biomass composition for E coli cell [39]and biomass yield (The details can be 
found in the Appendix 7.4), are needed as constraints for reducing the system’s degree of 
freedom. 
3.5 Network topology and choice of free fluxes  
In order to reduce the complexity of the metabolic models, reactions are combined for the 
following cases: 1) when the pools cannot be distinguished by any measurement, then 
lumping is justified for pools lying within a linear or cyclic reaction sequence conserving the 
C-atom skeleton and without any in- or efflux, such as lumping FBP with F6P. 2) When large 
exchange fluxes are exists between two metabolite pools, it is reasonable to lump them. 
The metabolic network reconstruction is mainly from Ecocyc database, literature data, and 
also the microarray data.  The central carbon metabolism pathway constitutes the backbone 
metabolic pathways in cell metabolism. At the first beginning of the network topology, the 
glycolysis pathway, pentose phosphate pathway, tricarboxylic acid cycle, Entner-Doudoroff 
pathway, C1 metabolism pathway and anaplerotic pathways has been included in the model. 
The degree of freedom can be obtained by F=J-K, in which J is total number of fluxes, K is 
total number of metabolites in the model[2]. If F is smaller than the total measurement M, it’s 
an underdetermined system. The free fluxes need to be calculated by fitting the experimental 
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isotopomer measurement and simulation isotopomer measurement through mathematical 
modeling by applying isotopomer balance [28-31].  The choice of the set of free fluxes is not 
as straightforward for complex models as the simple network model example in Wiechert’s 
papers [28-30]. The choice of the free fluxes does influence the simulation results. The 
results will be shown in Chapter 4 result and discussion section. Trial and error is a must in 
this case with the additional biological information to choose the right set of free fluxes. The 
general approach for choosing the free flux is to first identify the branch nodes in the 
metabolic pathways, which in literally, is the ones have more than two outlets. After the 
branch nodes are identified, the next step is trying to see whether there is one already known 
flux in the node. The bimolecular reactions are of special interest due to the bilinear relation 
will increase the complexity of the mathematic model [28, 29]. The trial and error procedure 
is mainly needed after the branch nodes are identified. 
On the other hands, the size of metabolic model will influence the flux estimation as well. 
This study investigates the influence of both free flux sets chosen and size of metabolic 
model on flux value estimation. The results can be found in Chapter 4.  
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CHAPTER 4 MECHANICS OF FLUX ANALYSIS   
4.1 Influence of the free flux on the simulation result of 
13
C flux analysis 
using NMR2Flux 
The set of free fluxes chosen will influence the result of the simulation even with the same 
isotopomer measurement sets, the same extracellular flux, and the same biomass flux. The 
following results are from labeling experiment conducted in M9 media with the same 
labeling glucose mixture for both the control condition and 35 mM C8 condition. NMR2Flux 
will examine the proposed metabolic pathway network by calling the function of ‘feasible 
flux ()’, after the proposed model and chosen free flux parameter has been passed, the 
program will continue for simulation[20]. The results shown here all passed the ‘feasible flux 
()’ examination, but the different sets of free fluxes can lead to different simulation results. 
The metabolic model includes the glycolysis pathway, pentose phosphate pathway, TCA 
cycle, anaplerotic pathway, glyoxylate pathway and the ED pathway. The highlighted 
intermediate metabolites are ‘branch nodes’ in the metabolic model, which is shown in 
Figure 4. There are 46 fluxes, 20 metabolites and 13 measured fluxes in the model, including 
transport fluxes (glucose uptake rate and acetate production rate) and biomass fluxes. 8 
reversible fluxes and 1 scramble flux have been included in the model as well which reduce 
the degree freedom to F=46-20-13-8-1=4. In order to get unique flux distribution of the 
system, 4 free flux need to be solved by NMR2Flux. Special attention has been paid to 
bimolecular reactions in these branch nodes, such as ACCoA and OAA, which can be 
converted into either isocitrate, or succinate and glyoxylate. Different sets of free fluxes have 
been tested in the same metabolic model with same biomass flux, isotopomer measurement 
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using NMR2Flux. The results of three sets free fluxes are shown in the following section. 
 
Figure 4 Metabolic network with highlighted branch nodes 
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The following table shows the details of the free flux sets and the flux range in the metabolic 
model.  
Table 1 Three sets of free fluxes for NMR2Flux simulation input 
Set 1 Set 2 Set 3 
Name Flux range Name Flux range Name Flux range 
eda 0 - 10 eda 0 - 10 eda 0 - 10 
talf 0 - 45 talf 0 - 45 pgkf 0 -200 
aceA 0 - 5 icd 0 -150 icd 0 -150 
ana 0 -10 ana 0 -10 ana 0 -10 
 
The results for each set of free fluxes are average values from 200 runs in NMR2Flux. The 
flux values in central carbon metabolism pathway were compared in the following Figure. 
Flux values are all normalized to 100 mol glucose consumed. 
  
Figure 5 Simulation results comparison between three different sets of free flux for control condition 
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Set 1 and Set 2 agree to each other pretty well except for the glyoxylate pathway. Under 
aerobic conditions, using glucose as the carbon source, the glyoxylate pathway is repressed 
which means the flux value should be negligible [16, 18, 19].Set 1 result agrees with this 
pretty well, while set 2 has a negative flux through glyoxylate pathway, which means the 
estimation is not consistent with biological knowledge. Set 3 is not a bad estimation as the 
glycolysis pathway has large back flow, as well as TCA cycle. And the simulation result for 
isotopomer of Set 3 doesn’t agree to the experiment result shown in Figure 6 while Set 1 and 
2 has a good fitting (data not shown). 
 
Figure 6 Simulation results of isotopomer abundance and experimental data fitting for Set 3 
In conclusion, the first step for choosing free flux is to identify the branch nodes in the 
metabolic flux network, and the trial and error procedure is one way to identify the effective 
set of free fluxes. The fitting of simulation and experimental data and biological knowledge 
can be used for criteria to identify the quality of the estimation.  
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4.2 Model size influence the estimation of flux value 
For 
13
C flux analysis, in order to get reliable flux estimation, the size of the metabolic model 
is limited, and lumping reactions is one way for reducing the complexity of metabolic model. 
Most of the studies in E coli central carbon metabolism include glycolysis, TCA cycle, 
pentose phosphate pathway, anaplerotic pathways as the backbone in central carbon 
metabolism [16, 18, 19]. In order to study the toxicity effect of octanoic acid on metabolic 
fluxes, a comprehensive model is needed for identify the pathways which have flux 
alteration. Several sources are used to develop the topology of the metabolic networks for 
aerobic metabolism, i.e. Ecocyc pathway database, the large-scale isotopomer model by C. 
Maranas[17], and transcriptomic data from the Dr. Jarboe lab. Two metabolic models have 
been constructed for comparison, which were shown in following Figures. Model1 includes 
the major pathways in central carbon metabolism along with the ED pathway and glyoxylate 
pathway, which are assumed to be inactive when glucose is the only carbon source in 
literature data [16, 18, 19]. Thus, the ED pathway and glyoxylate pathway were used as 
criteria for screening the simulation result for different metabolic models and free flux sets. 
In addition to the same central carbon metabolism pathways, several amino acid 
transamination reactions and biosynthetic pathways have been included in Model 2. Model 1 
includes 23 metabolites, 51 fluxes with 15 measured fluxes, 8 reversible fluxes, 1 scramble 
flux and 4 free fluxes. Model 2 includes 32 metabolites, 93 fluxes with 23 measured fluxes, 
27 reversible fluxes, 2 scramble flux and 9 free fluxes. 
The following result will show the difference between Model 1 and Model 2 for the same set 
of isotopomer measurements, biomass measurements and extracellular flux measurements. 
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Figure 7 metabolic network Models 1 
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Figure 8 Metabolic network for Model 2 
The result shown in following graph is for one biological replicate of control condition in 
both models. The simple model represents Model1, and the full model represents Model 2. 
The data shown are average from 200 runs in NMR2Flux. 
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Figure 9 Flux comparison between Model 1 (simple model) and Model 2 (full model) 
The two models have similar flux in the glycolysis pathways, and pentose phosphate 
pathway. Both models gave negligible value for ED pathway and glyoxylate pathway, which 
is consistent with literature data for E. coli fermentation on glucose [16, 18, 19]. But large 
difference has been observed in the pyruvate kinase pathway (pyk), PEP carboxylation 
pathway, TCA cycle and malic enzyme pathway. The flux distribution through pyruvate node 
is different between Model 1 and Model 2, which may due to the Model 2 involves pyruvate 
in both serine degradation pathway and alanine biosynthesis through the glutamate 
transamination pathway. The Figure 10 and 11 show the fitting between experimental 
measurement and simulation result for both models. 
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Figure 10 Fitting between experimental data and simulation result in model 1 
 
Figure 11 Fitting between experimental data and simulation result in model 2 
The Model 2 has better fitting in terms of larger R
2
 value. The more comprehensive model 
gives better estimation of intracellular flux distribution. Transamination reactions for those 
amino acids, which have relatively large pool sizes, such as glutamate influence carbon 
labeling pattern, as well as central carbon flux distribution. The flux analysis has been 
performed on both models for toxicity effect study of C8 in order to give better ideas about 
the explanation of C8 toxicity. 
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4.3 The difference between GC-MS and NMR for isotopomer 
measurements in identification of flux analysis 
GC-MS and NMR can be both used for measuring the amino acids isotopomer distribution. 
Theoretical, GC-MS gives less positional isotopotomer information than NMR since GC-MS 
gives m+1 for all one-carbon label peaks no matter where the label carbon position is. 
Additionally, GC-MS doesn’t have information about histidine, due to the less stability of 
histidine derivatives, while NMR measured has relative noisy measurement for histidine. To 
compare the difference of these two measurements, proteinogenic amino acids have been 
measured both in GC-MS and NMR for one biological replicates. The labeling experiment 
was conducted in MOPs media under aerobic condition, with 25% 1-label glucose, 10% U-
label glucose, and 65% nature glucose. The following flux map shows normalized flux 
results for both control and 20 mM C8, flux value for control condition result in black and for 
20 mM C8 result in red respectively.  The R values in ‘< >’ are the reversibility for each of 
the reversible reactions which is defined as   
   (     )
   (     )
, V1 is flux value of forward 
reaction, V-1 is flux value of reverse reaction. All the flux values are normalized into 100mol 
of glucose are consumed. The green solid arrows are amino acid biosynthesis pathways. 
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Figure 12 Flux map for both control condition and C8 stress obtained from NMR2FluxPlus using GCMS data, the 
values in black are control condition, the values in red are C8 stress. 
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Figure 13 Flux map for both control condition and C8 stress obtained from NMR2Flux using NMR data, the values 
in black are control condition, the values in red are C8 stress.  
Most of the pathway steps have similar flux values for GC-MS generated maps versus NMR 
generated maps, except that the GC-MS based flux map does not estimate the reversibility of 
the reactions correctly, the reversibility has large standard deviation. Scatter plots of 
simulated versus experimental isotopomer intensities indicates that while NMR data is more 
noisy than GC-MS, it provides more comprehensive coverage of labeling in the metabolic 
network. The scatter plots for both measurements have been shown in following Figures.
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Figure 14 NMR data fitting with simulation data 
 
 
Figure 15 GC-MS data fitting with simulation data 
Due to the limitation of the GCMS for reversibility extent determination, the 
13
C flux 
analysis for toxicity effect of C8 (shown in Chapter 5) only used the NMR data.
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CHAPTER 5 METABOLIC FLUX RESPONSE TO 35 mM C8 IN E. 
COLI MG1655  
The results of 
13
C flux analysis of Escherichia coli MG1655 under 35 mM C8 stress show 
that the TCA cycle flux is inhibited by ~ 44%, malic enzyme pathway is inhibited by ~ 80%, 
phosphoenolpyruvate carboxylase pathway is inhibited by ~ 60%, CO2 production rate 
decreases by 18% and pyruvate dehydrogenase pathway is inhibited by ~50%, meanwhile, 
the pyruvate dehydrogenase flux (‘poxB’) becomes active under C8 stress, the malate 
dehydrogenase pathway in TCA cycle increases by ~55%, the extracellular acetate flux 
increases by ~ 80% . One tail T test for three biological replicates shows that the following 
pathways are significant difference between control condition and C8 stress.  
5.1 Culture condition optimization for 
13
C flux analysis  
5.1.1 Glucose level 
In order to study the toxicity effect of C8 under aerobic condition in carbon rich defined 
media, two different amounts of glucose have been investigated.  
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Figure 16 Growth rate comparison under different media conditions, data shown are from 3 biological replicates. 
20 g/L (2% weight) and 10 g/L (1% weight) of glucose have been added into MOPs media, 
and the growth rates were compared under different concentrations of C8 in shake flask 
cultures. HPLC analysis of the media with 1% glucose (10g/L) in the beginning of stationary 
phase indicated that glucose is in excess (around 7.0 g ± 0.25 g left in the media). With this 
information and the result that under different level of glucose, the growth rate under does 
not dramatically change, which means the carbon source is not limiting the cell growth.  In 
order to save on the cost for labeled glucose, 1% glucose has been used for the flux 
experiments. 
5.1.2 Bioreactor or shake flask 
Growth rates for culture conducted in the bioreactor with 400 ml working volume was 
compared with 250 ml shake flasks that have 25 ml working volume. 
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Figure 17 Growth rate comparison between bioreactor and shake flasks, data shown are from duplicates. 
The results shown in Figure 17 that under the same C8 stress, cells grows better in bioreactor, 
which equipped with pH control, and aeration. In order to eliminate the influence of 
extracellular pH on cell growth, bioreactor was chosen for performing flux analysis of E. coli 
under C8 stress. 
The cell growth was inhibited by 15.18%±0.04% (n=2) in the bioreactor under 20 mM C8 
with MOPs media. The phenotype difference is not significant except the growth rate 
(with criteria that p <0.05) under this condition (data not shown). A higher level of 
inhibition is desired in order to have sizeable differences in the physiological state. 
Meanwhile, in order to get enough biomass for NMR analysis, transcriptome analysis 
and proteomic analysis, M9 minimum media was used because it has higher N content 
than MOPs media (M9 media contains 14.96 mM of N, MOPs media contains 9.53 mM of 
N), which enables the higher cell density at the end of log-phase (OD550 increases from 
2.0 to 2.55 by switching from MOPs media to M9 media).  
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To sum up, after culture condition optimization, the metabolic flux analysis of E. coli under 
octanoic acid stress was performed in bioreactor with 35 mM C8 in M9 media supplemented 
with 1% glucose. Three 
13
C-labeling experiments have been conducted, and the results of the 
flux analysis shown in this paper are from these experiments.  
5.2 Phenotype comparison of E. coli MG1655 under control condition and 
35 mM C8 stress condition 
The detailed calculations for biomass yield, acetate production rate, specific glucose uptake 
rate, specific acetate production rate and specific oxygen uptake rate were shown in Chapter 
3 and in the Appendix 7.5. The results shown in following Figure are the average value from 
three biological replicates. The individual result for each biological replicate can be found in 
the Appendix 7.6. 
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Figure 18 The phenotype comparison between control and 35 mM C8 stress, and the shown data are from three 
biological replicates. 
As shown in Figure 18, the acetate yield and specific acetate production rate are increased by 
1.82 fold and 1.34 fold respectively, while the growth rate, biomass yield, and specific 
glucose uptake rate are decreased by 2.02 fold, 1.53 fold, and 1.35 fold respectively. The 
average value for each term has been listed in the Table 2 with fold change as well. A one-
tail T test of the 3 biological replicates shows the differences in the phenotype are significant 
(p value <0.05, data shown in Appendix). 
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Table 2 The phenotype difference comparison between control condition and 35 mM C8, with fold change 
information (‘-‘ sign means decrease). 
Culture 
conditions 
Growth rate Biomass yield Acetate yield 
Specific uptake rate 
of glucose 
Specific production rate of acetate 
hr-1 
mol biomass/mol 
glucose 
mol acetate/mol 
glucose 
mmol/g. CDW.hr mmol/g.CDW.hr 
Control 0.7577 2.6547 0.4002 11.4558 4.4827 
SD 0.0301 0.2482 0.1206 1.4147 1.0013 
35 mM C8 0.3744 1.7297 0.7275 8.4982 6.0034 
SD 0.1150 0.2150 0.1498 1.8016 0.2545 
Fold change -2.02 -1.53 1.82 -1.35 1.34 
5.3 Proteinogenic amino acids labeling distribution comparison between 
control condition and 35 mM C8 stress condition 
The labeling information about intracellular metabolite is obtained by measuring the labeling 
pattern of proteinogenic amino acids, as each of the amino acid peaks can be traced back into 
the individual carbon backbone of their precursor metabolite. The 2D (
13
C,
1
H) HSQC NMR 
measurement data for all three biological replicate sets are attached in the Appendix with the 
information about the carbon backbone isotopomer information in both the amino acids and 
their specific precursors.  
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Figure 19 Amino acid labeling pattern is significant different in the shown ones according to the one tail T test result. 
Amino acid peaks with high resolution (amino acids with double doublet labeling pattern 
have been excluded for comparison as peak de-convolution has been applied which leads to 
relatively high measurement noise) have been compared using one-tail T test. The amino 
acids shown in the above Figure and following table are the ones with significant difference 
between control and C8 stress according to the result of T test with criteria of P value<0.05. 
The following table gives value for each amino acid peak shown in Figure 19.
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Table 3 Isotopomer average measurements from three replicates of amino acids, which have significant difference 
under control condition and C8 stress, the shown P value is from one tail T test. Peak type ‘s’ represents ‘singlet’, ‘d’ 
represents ‘doublet’, ‘t’ represents ‘triplet’, ‘dd’ represents ‘double doublet’. The ‘α, β, ϒ, δ’ represents the position 
of carbon in carbon chain of amino acids. 
  carbon peak         
  position  type Control SD 35 mM C8 SD P value 
ALA_β_s 3 s 0.3464 0.0094 0.3607 0.0076 0.05 
ALA_β_d 3 d 0.6536 0.0094 0.6393 0.0076 0.05 
ARG_β_s 3 s 0.2415 0.0101 0.3361 0.0099 0.00 
ARG_β_d 3 d 0.5299 0.0020 0.4737 0.0007 0.00 
ARG_β_t 3 t 0.2287 0.0086 0.1901 0.0097 0.00 
ARG_δ_s 5 s 0.0894 0.0036 0.0990 0.0015 0.01 
ARG_δ_d 5 d 0.9106 0.0036 0.9010 0.0015 0.01 
GLU_β_s 3 s 0.2022 0.0083 0.3036 0.0161 0.00 
GLU_β_d 3 d 0.5611 0.0041 0.5020 0.0066 0.00 
GLU_β_t 3 t 0.2367 0.0070 0.1944 0.0109 0.00 
GLY_α_s 2 s 0.1249 0.0142 0.1458 0.0084 0.05 
GLY_α_d 2 d 0.8751 0.0142 0.8542 0.0084 0.05 
HIS_δ_s 5 s 0.3025 0.0065 0.4272 0.0358 0.00 
HIS_δ_d 5 d 0.6975 0.0065 0.5728 0.0358 0.00 
ILE_β_d 3 d 0.7465 0.0032 0.6481 0.0097 0.00 
ILE_β_t 3 t 0.2272 0.0046 0.3275 0.0113 0.00 
ILE_δ_s 5 s 0.4389 0.0104 0.4078 0.0115 0.01 
ILE_δ_d 5 d 0.5611 0.0104 0.5922 0.0115 0.01 
LEU_β_t 3 t 0.1236 0.0030 0.1338 0.0017 0.00 
LEU_δ_s 5 s 0.4190 0.0194 0.4473 0.0073 0.04 
LEU_δ_d 5 d 0.5810 0.0194 0.5527 0.0073 0.04 
LYS_ϒ_s 4 s 0.2211 0.0177 0.1714 0.0223 0.02 
LYS_ϒ_t 4 t 0.2358 0.0073 0.3008 0.0308 0.01 
LYS_δ_d 5 d 0.5164 0.0040 0.5263 0.0007 0.02 
LYS_δ_t 5 t 0.2888 0.0126 0.2545 0.0184 0.04 
PRO_β_s 3 s 0.1744 0.0083 0.2417 0.0372 0.02 
PRO_β_d 3 d 0.5364 0.0104 0.5136 0.0090 0.02 
PRO_β_t 3 t 0.2892 0.0042 0.2446 0.0284 0.03 
PRO_ϒ_s 4 s 0.1490 0.0009 0.1663 0.0032 0.00 
PRO_ϒ_d 4 d 0.5729 0.0082 0.5582 0.0048 0.03 
VAL_ϒ_s 4 s 0.3069 0.0217 0.3426 0.0055 0.03 
VAL_ϒ_d 4 d 0.6931 0.0217 0.6574 0.0055 0.03 
SER_β_s 3 s 0.4653 0.0032 0.5413 0.0343 0.01 
SER_β_d 3 d 0.5347 0.0032 0.4587 0.0343 0.01 
 
The peaks highlighted in red in above table, are those have relative high absolute difference 
in the isotopomer fraction, which suggesting the flux distribution through their precursor 
nodes are changed under C8 stress. The precursor nodes, which relate to the highlighted 
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amino acids, are α-ketoglutarate, oxaloacetate, pyruvate and ribose-5-phosphate, which are 
mainly involved in the TCA cycle, pyruvate node and pentose phosphate pathway. Metabolic 
flux changes in these pathways are expected based on the observation of the labeling pattern 
in the amino acids.
5.4 Flux maps comparison  
Two models described in Chapter 4 have been constructed for 
13
C flux analysis. The reaction 
networks for both models can be found in Appendix 7.8; meanwhile, the detailed normalized 
flux value has been included of the average flux value for the three individual biological 
replicate sets are shown in Appendix 7.9. Flux maps for the control and C8 stress condition 
are shown in Figures 20, 23 and 21, 24 for Model 1 and Model 2, respectively. The Model 2 
includes several amino acids transamination pathways and biosynthesis pathways and all 
central carbon metabolism pathways in Model1. The flux values shown are the average value 
(plus standard deviation) of fluxes generated from each of the three biological replicates. The 
values in black are for control condition, and the values in red are for 35 mM C8 stress 
condition. The following flux maps have highlighted the pathways for which the flux is 
altered upon C8 stress. The solid green arrows show those fluxes that increase when the cells 
are under stress, the solid orange arrows show those that decrease when under stress, the ones 
in black show no dramatically difference (p > 0.05) between the control and stress 
conditions. 
Model 2 has better flux determination, as the standard deviation is smaller than Model 1(for 
all three biological replicates). Meanwhile, same as described in Chapter 4, the fitting of 
NMR measurement of amino acid isotopomer fraction between the simulation result and 
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experimental data is better for Model 2 than Model 1 shown in Figure 24 and 25 respectively 
(only for control condition from one biological replication). 
 
Figure 20 Flux map comparison between control and C8 stress of Model 1. The pathways highlighted in green bold 
arrows, are representative for the reactions that are active under C8 stress, those highlighted in red bold arrows are 
reactions that are inhibited under C8 stress, and those arrows in black are for pathways that doesn’t have statically 
significant flux change. The values along with those arrows are the flux value for each condition, in which the value 
in black is for control condition, and the value in red is for stress condition 
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Figure 21 Flux map comparison between control and C8 stress in Model 2. The pathways highlighted in green bold 
arrows, are representative for the reactions that are active under C8 stress, those highlighted in red bold arrows are 
reactions that are inhibited under C8 stress, and those arrows in black are for pathways that doesn’t have statically 
significant flux change. The values along with those arrows are the flux value for each condition, in which the value 
in black is for control condition, and the value in red is for stress condition 
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Figure 22 Flux value comparison of Model1 for both control and 35 mM C8, data shown are average from 3 
biological replicates 
 
Figure 23 Flux value comparison of Model 2 for both control and 35 mM C8, data shown are from three biological 
replicates.
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Figure 25 The measured isotopomer fraction fitting with simulation result for Model2 of one biological replicate for 
control condition 
The average normalized flux value has been summarized in the Appendix 7.9 for both 
control condition and C8 stress. The following section will include the NADH, NADPH 
cofactor production and ATP energy production for Model 2. 
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Figure 24 The measured isotopomer fraction fitting with simulation result for Model1 of one 
biological replicate for control condition  
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5.5 Cofactor (NADH, NADPH) production and ATP 
The 
13
C flux analysis does not include any redox balance information for flux calculation but 
just the extracellular flux measurements and the isotopomer labeling pattern of proteinogenic 
amino acids for flux determination. The net flux for cofactor production can be calculated by 
summing up the pathways, which produce cofactors and subtracting, the pathways consume 
cofactors. The following table includes the pathways for cofactor production and 
consumption in the central carbon metabolism pathways for the metabolic models used in 
13
C 
flux analysis for E coli MG1655 under aerobic conditions.  
The cofactor production pathways have been visualized in the following Figure with different 
symbols representing NADH, NADPH and ATP respectively.  
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Figure 26 NADH, NADPH and ATP production in central carbon metabolism pathways 
NADPH is produced in oxidative branch of pentose phosphate pathway, TCA cycle, and 
malic enzyme pathway. Two different enzymes can convert malate into pyruvate and CO2. 
One is NAD+ linking enzyme (encoded by maeA gene[43]), the other one is NADP+ linking 
enzyme (encoded by maeB gene[44]). The pathway catalyzed by maeA needs NAD+ and 
produces NADH [43], while the one catalyzed by maeB needs NADP+ and produces 
NADPH [44]. Since the flux analysis constructs the metabolic pathway models from the 
knowledge of stoichiometric constraints, as well as carbon skeleton rearrangement, reactions 
have the same stoichiometric constraints and same carbon rearrangement cannot be 
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distinguished by 
13
C flux analysis. Thus, the malic enzyme pathway catalyzed by these two 
different enzymes can’t be identified by flux analysis. Other biological information such as 
literature data or the corresponding microarray data could be used for confirming if both 
enzymes are active under aerobic condition. Unfortunately, this transcriptome information 
fails to give the quantitative description about the in vivo enzymatic reaction rate. So when 
calculating the cofactor production rate, those pathways that can be catalyzed by more than 
one enzymes, which lead to different cofactor production, are considered as the measurement 
error, which were illustrated by reactions with ‘*’ in the Table 4. 
Table 4 NADH,NADPH,ATP production in central carbon metabolism 
 Reaction  Enzyme  Stoichiometric equations Pathway 
NADPH zwf zwf G6P+NADP
+
 -> 6PG+NADPH 
Oxidative branch in PP 
pathway 
 
rpi gnd 
6PG+NADP+ -> Ru5P+NADPH+CO2 
Oxidative branch in PP 
pathway 
 
icdh icd ICT+NADP+ ->AKG+CO2+NADPH TCAcycle 
 
ana* maeB MAL+NADP+->PYR+NADPH+CO2 Malic enzyme pathways 
NADH ace lpd,aceF,aceE PYR -> AcCoa+CO2+NADH Pyruvate dehydronase 
 
suc lpd,sucA,sucB AKG->SUC+CO2+NADH+ATP TCA cycle 
 
mdh* mdh MAL->OAA+NADH TCA cycle 
 
ana* maeA MAL->PYR+NADH+CO2 Malic enzyme pathways 
 
pgk gapA G3P -> 3PG + NADH + ATP Glycolysis 
ATP pyk pykF, pykA PEP -> PYR + ATP Glycolysis 
 
fbp pfkA, pfkB F6P + ATP -> F16P Glycolysis 
 
suc sucC, sucD α-AKG -> SUC + CO2 + NADH + ATP TCA cycle 
 
pgk pgk G3P -> 3PG + NADH + ATP Glycolysis 
As illustrated in Table 4, the flux through malic enzyme pathway (‘ana’) is treated as 
measurement error for both NADPH production and NADH production, the flux through 
malate dehydrogenase reaction (‘mdh’) is treated as measurement error for NADH 
production since there are two enzymes catalyze the same reaction which leads to different 
cofactor NADH production. One is encoded by mdh gene[45], which catalyzes malate to 
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generate oxaloacetate, using NAD+ as an electron acceptor, and the other one is membrane-
associated enzyme encoded by mqo gene[46], which catalyze the same reaction and coupled 
with electron donation to electron transport chain at the quinone level. The total production 
of NADH, NADPH, and ATP in central carbon metabolism was shown in the Figure 27 with 
the measurement error (which has been described in the previous section) for metabolic 
Model 2 only. 
 
Figure 27 Total NADH, NADPH and ATP production 
The results show that the total NADH, NADPH production has been inhibited under C8 
stress. The pathways has included the glycolysis pathway, the measured error bars for NADH 
production come from pathway in TCA cycle (‘mdh’ pathway) for malate dehydrogenase and 
malic enzyme pathway catalyzed by maeA[43] as well. The overall ATP production is 
slightly higher for stress condition.  
The NADH production and ATP production in glycolysis pathway have been compared in 
the Figure 28. Interestingly, the C8 stress condition has more ATP production in the 
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glycolysis pathway than control condition, and the NADH production is similar for both 
conditions for glycolysis pathway. 
 
Figure 28 NADH and ATP production in glycolysis pathway 
From the flux map, the TCA cycle has been inhibited under C8 stress by ~44%. The 
production of NADPH, ATP decreases in the TCA cycle as expected, while the NADH 
production has large measurement error since two different malate dehydrogenases (mdh[45] 
and mqo[46]) can’t be distinguished by flux analysis as described in previous section. 
In the following section, the result for 
13
C flux analysis will be summarizes, the hypothesis 
for explaining flux changes under C8 stress will be proposed, and the strategies for 
improving the strain tolerance will be suggested as well. 
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Figure 29 NADH, NADPH, and ATP production in TCA cycle
5.6 Summary of the flux analysis 
The results of 
13
C flux analysis have identified the following pathways in central carbon 
metabolism that are altered when the cells are under C8 stress. 
1) TCA cycle flux, specifically the citrate synthase pathway is inhibited by ~40% 
2) Malic enzyme pathway is inhibited by ~80% 
3) Phosphoenolpyruvate carboxylase pathway is inhibited by ~ 60% 
4) CO2 production rate decreases by ~18%  
5) Pyruvate dehydrogenase pathway is inhibited by ~50% 
6) Pyruvate dehydrogenase flux (‘pox’) becomes active under C8 stress 
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7) The malate dehydrogenase pathway in TCA cycle increases by ~55% 
8) The extracellular acetate flux increases by ~ 80% 
9) The ATP production is higher in glycolysis pathway when under C8 stress 
10)  The overall cofactor production (NADH, NADPH) is lower for stress condition. 
5.7 Discussion 
5.7.1 Hypothesis of C8 toxicity effect 
In order to interpret the flux change for C8 stress, hypothesis has been proposed about the C8 
toxicity mechanism shown in Figure 30.  
 
Figure 30 Illustrations about hypothesis about C8 toxicity mechanism. When the cell exposed to C8, the membrane is 
disrupted, which could cause the functional disruption of membrane bound proteins, such as Ndh, cytochrome 
oxidase, and ATP synthase. The low activity of these enzymes will leads to low efficiency of electron transport chain, 
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as well as NADH turnover difficulty. The resulting high intracellular NADH concentration and low NAD+ 
concentration will lead to the inhibited fluxes in TCA cycle, pyruvate dehydrogenase pathway, malic enzyme 
pathway, which fits the result of 13C flux analysis. Meanwhile, the low activity of PDH pathway may also caused by 
PdhR (pyruvate sensing) regulation, which also represses the ndh and cyoABCDE, and in turns influence the 
efficiency of electron transport chain as well. 
First of all, the membrane integrity is disrupted under C8 stress according to membrane 
fluidity study conducted by Dr. Jarboe’s group. They have proven that short chain fatty acids 
do have an impact in membrane properties, as higher concentrations lead to permanent 
disruption of membrane fluidity (Jarboe, unpublished data). The membrane disruption leads 
to destabilization of membrane-bound proteins, such as NADH dehydrogenase. The 
malfunction of this enzyme will cause the difficulty for NADH turnover, leading to 
intracellular NADH accumulation, and NAD+ deficient. The pathways that are sensitive to 
NADH level will response to the accumulation of NADH, such as the citrate synthase 
activity is inhibited [47, 48], and the subunit of lipoamide dehydrogenase (lpd) E3 monomer 
in pyruvate dehydrogenase multi-enzyme complex is inhibited by high NADH level [49]. 
This hypothesis is consistent with the result of flux analysis that the flux of TCA cycle and 
pyruvate dehydrogenase pathway is lower when under C8 stress. While the other pathways 
(such as TCA cycle and malic enzyme pathway) that needs NAD
+
 as substrate will also 
responds to the deficient intracellular NAD
+
. The flux change in following pathways 
suggesting insufficient supply of NAD+ when under C8 stress: 
a) The ‘Pox’ [50] pathway, which does not relied on  NAD+ availability is active 
under C8 stress. Rerouting the flux from pyruvate dehydrogenase multienzyme complex to 
‘Pox’ can reduce also the NADH production. The activation of pox usually happens at low 
growth rates in E coli [50], which fits the growth condition when under C8 stress. 
53 
 
 
b) The flux through malic enzyme pathway decreased dramatically when under stress 
since the one of the malic enzyme that encoded by maeA need NAD+ binding to be active 
[43].  
 c) The low activity of TCA cycle is the other evidence for NAD+ deficient. Since 2 
mol of NADH can be produced from NAD+ for TCA cycle, the limited NAD+ availability 
will limits the traffic of TCA cycle. 
Secondly, the electron transport chain of Escherichia coli is disrupted when under C8 stress. 
The electron transport chain will not function well when the membrane is not stable, similar 
effect has been observed when E coli exposed to sublethal concentration of antimicrobial 
peptide Bac8c [51], which results in transient membrane destabilization as well as inhibition 
of electron transport chain. The aerobic respiration chain can function with either of two 
different membrane-bound NADH dehydrogenases (NDH-1 and NDH-2). Due to the 
membrane integrity disruption, the function of several membrane-bound enzymes has been 
perturbed. The low activity of NADH dehydrogenases leads to low capacity of aerobic 
respiration rate under C8 stress [52].The oxygen uptake rate for the cell decreased when cell 
is under stress as shown in Figure 31, which suggesting the low activity of respiration chain 
due to the limited availability of terminal electron acceptor (Oxygen). The respiration 
repression can also leads to the decreasing in endogenous O2-, results in reductive stress. 
Reductive stress will lead active Fur which need requires binding ferrous iron (Fe2+) to 
become active as shown in Figure 32 [53], which is similar with the isobutanol toxicity 
mechanism. The hypothesis of activation of Fur fits the color difference in biomass 
hydrolysis shown in following Figure 33 for control and C8 stress pretty well. The C8 stress 
biomass has light green, which may be due to the increasing intracellular concentration of 
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Fe
2+
. 
 
Figure 31 The dissolved oxygen curve for all three sets replicates for exponential phase. The time 0 shows when 
exponential growth starting point. As the Figure suggests, the cell respiration rate is different between Control 
condition and 35 mM C8 
 
Figure 32 Isobutanol response network related to quinone malfunction[53] 
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Figure 33 Around 24mg of Biomass pellet with 6ml 6N HCL, under room temperature 
On the other hand, The low activity of the electron transport chain leads to less ATP 
production [54] through proton-translocating ATPase, which catalyzed ATP synthesis from 
ADP and Pi during aerobic condition. The excess ATP production in glycolysis pathway for 
stress condition suggesting that the cell is trying to replenish the ATP production by active 
the glycolysis pathway. Finally, to explain the flux change in TCA cycle, and flux for acetate 
production, four transcription factors, ArcA, PdhR, IHFA, and IHFB, are targeted basing on 
literature data[55]. However, the transcription factor analysis basing on flask experiment 
with 10 mM C8 shows no difference in ArcA, but slight difference in PdhR and IHFA 
(Jarboe, unpublished data). The pdhR upregulation has been observed from precious work of 
E coli exposed to several organic acids and inorganic acids [56]. pdhR plays a key role in the 
metabolic interconnection between glycolysis and the citric acid cycle and is an important 
regulator for the steady state maintenance of the central carbon metabolism for energy 
production in response to changes in environmental conditions[57, 58]. PdhR has been found 
to be a master regulator for controlling the PDH complex and the respiratory electron 
Control 35 mM C8 
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transport chain system formation [55]. Flux analysis suggesting that pyruvate dehydrogenase 
pathway decreased under C8 stress, suggesting the less activity of the pyruvate 
dehydrogenase complex encoded by aceEF and lpdA. Meanwhile, the PdhR regulator is 
known for pyruvate-sensible [57, 58]. When pyruvate is available, PdhR will bind with 
pyruvate instead of binding to the target promoter, which represses the PdhR regulator effect 
(the inhibition of the transcription of 'pdhR-aceEF-lpdA' operon will only happen when PdhR 
binds to the target promoter). The hypothesis is that when the cell is under C8 stress, the 
intracellular concentration of pyruvate will decrease, which allows more PdhR binding to the 
target promoter, resulting into the inhibition of transcription of the  'pdhR-aceEF-lpdA'operon 
as well as 'ndh' and 'cyoABCDE'. Consequently the repression of ndh and cyoABCDE leads 
to the low efficient of NADH turn over as well as the low efficient of respiration chain. This 
hypothesis of pdhR upregulation can be verified both by transcription factor analysis and the 
activation of PdhR can also be verified by evaluating the intracellular pool of pyruvate for 
cell under stress and control condition.  
5.7.2 Possible strategies for increasing the tolerance of C8 
a) If the hypothesis of PdhR is true, adding pyruvate into the media will help the cell to 
recovery from the stress by derepression of ndh and cyoABCDE [55], which enable 
the turnover of NADH into NAD+. The primary experiment result shows that adding 
pyruvate into media helps the cell partially recover from stress as shown in Figure 33. 
b) Replace the enzymes that are sensitive to high NADH level with enzymes which are 
not sensitive to NADH level in order to keep the high activity in TCA cycle, which 
provides enough biomass flux for higher growth rate, such as replacing the citrate 
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synthase with that is not inhibited by high NADH level. This has been done by Dr. 
Jarboe’s group (unpublished data), and the results are quite encouraging. Since more 
than one enzyme is inhibited by NADH, all of them should be replaced in order to 
help the cell recover from C8 stress. 
c)  Recover the respiration chain by either providing other terminal electron acceptor in 
steady of oxygen or overexpressing genes, such as such as ndh, and cyoABCDE, 
which encode the proteins in the electron transport chain. 
 
Figure 34 The growth curves for E. coli in M9 media with different level of pyruvate in the media. The data show the 
improvement in cell growth when pyruvate is added into the media. 
The 
13
C flux analysis successfully identified the pathways that are influenced by C8 stress, 
the hypothesis was proposed for interpreting the flux change by integrating transcriptomics, 
proteomics results, and membrane fluidity study. The effort for integration is worthy for 
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clarifying the metabolic regulation for certain condition. More than one strategies have been 
proposed basing on the hypothesis, since several factors are proposed for explaining the 
toxicity effect. 
59 
 
 
CHAPTER 6 FUTURE WORK 
6.1 Incorporate the 
13
C metabolic flux analysis result into COBRA toolbox 
for prediction cell behavior under certain objective functions 
The long-term goal for metabolic engineers is analysis, interpret and ultimately prediction of 
the cell behavior under certain gene-modification or culture condition change. 
13
C metabolic 
flux analysis does a decent job by obtaining the reliable intracellular flux distribution through 
different techniques for monitoring intracellular information. Meanwhile, by integrating with 
other ‘omics’ analysis, the cell behavior can be interpreted as a complete system. The 
ultimate goal of this is built on the foundation of the analysis and interoperation of   cell 
behavior under different conditions. One approaches to fulfill the goal is constructing a 
genome-scale metabolic model from the annotated genome sequence, and using constraint-
based analysis for the prediction of flux changes when the objective functions changes. 
Along with the usual mass balance, energy balance, incorporating the 
13
C flux data will be 
additional constraints, which help constraint-based analysis to get the unique solution 
[reference: flux balance analysis: a genometric perspective].   
Incorporating the 13C flux analysis result into the model extracted from ecocyc by one of my 
collaborator for prediction of increasing the tolerance of fatty acid and increasing the yield of 
fatty acids as well. 
6.2 Verify the hypothesis of the mechanism for fatty acid toxicity effect 
There are two approaches for verification the hypothesis. First of all, integrate the 
13
C flux 
analysis with microarray data and proteomics data for the sample from the same set 
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experiment. Linking the flux alternation with those information (transcriptom and proteomics 
data) can help to identify the regulation for the C8 toxicity, which in turns to help 
engineering strain for better tolerance.  
Secondly, since the pathways, which have significant, flux alteration under C8 stress has 
been identified, and the hypotheses for interpreting of the flux change have been included in 
the results and discussion sections. The future work for verifying these hypotheses and also 
trying to improve the tolerance of E coli for short chain fatty acids is trying to do the gene 
manipulation basing on the strategies we proposed in the discussion part. 
6.3 Identify the potential gene target for high yield of fatty acid production 
By performing the flux analysis on the strain which can produce fair amount of fatty acids, 
and identify the flux alternation in the central carbon metabolism, using the same strategy 
described in this thesis.  The result from the 
13
C flux analysis can be used in COBRA toolbox 
for cell behavior prediction.
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APPENDIX 
7.1 Protocol for GC-MS sample preparation [15]  
1) 1.5 ml of OD550 0.8-1.5 (approximately 0.3-0.8 mg) of cell culture has been harvested by 
centrifuging for 5 minutes at 13,500 g, 4 °C.  
2) Discard the supernatant, and wash the cell pellet with 0.9% 1 ml of sodium chloride 
(NaCl) at 4 °C by centrifuging described by step1 for twice, and remove the supernatant. 
Note: you can stop at this step by storing the pellet in -40°C. 
3) Suspend the cell pellets in 200 μl of 6N HCL. Transfer the suspended cell into 2 ml tubes 
and seal the tubes in order to prevent the evaporation of HCL. 
Note: operate under fume hood  
4) Bake the well-sealed 2 ml tubes for 12-24 hours in heating blocks at 105°C (make sure the 
temperature is accurate to prevent destroying some amino acids). 
5) Dry the hydrolysate at 95 °C with constant airflow (or N2 gas flow) in the fume hood until 
the sample is complete dry. Bake the dried samples at 105°C for another 10 minutes to make 
sure that no moisture is left. 
6) Add 200ul nanopura water to reconstitute the dried sample, transfer into filter centrifuge 
tubes, and centrifuge at 13,500 g for another 1 or 2 minutes to get rid of the ash. 
7) Transfer into clean 2 ml tubes, and repeat step (5) again until samples are completed dried.  
8) Add 20 μl of Dimethylformamide (DMF) to the dried sample, the solvent may turn slight 
brownish, add another 20 μl of Trifluoromethanesulfonic acid tert-butyldimethylsilyl ester 
(TBDMSTFA) and seal well. 
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9) Incubate the 2 ml tube in heating block at 85 °C for another 1 hour under fume hood. 
10) Transfer the sample into GC-MS vial and seal with a cap. 
11) Perform the GC-MS measurement applying the method described in materials and 
methods section 3.3.1[15]  
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7.2 Protocol for fatty acid extraction and analysis method using GC-MS 
with direct injection (without derivatization) 
The protocol is used for free fatty acid extraction in media, and the recommended final 
concentration of fatty acid is 0.1-1 μg/1μL, the column used is CP-Wax 58(FFAP) CB, which 
can separate up to 20 carbon length of fatty acids without derivatization. 
1) Get 2.5ml of cell culture 
2) Centrifuge at 4000g for 10min 
3) Get 2ml of supernatant to a clean tube  
Note: If you want to stop at this step you can do this by store your sample at -20°C 
freezer. 
4) Add 200 μL of HCL (1M HCL) and internal standards  
5) Add 4ml methanol-chloroform (1:1) 
Note: the ration of methanol-chloroform with media solution (2:1) is important for 
phase separation, and extraction efficiency. 
6) Vortex for 10 min and then centrifuge at 4000g for 4 min 
7) Transfer lower layer (chloroform) to a clean test tube. Evaporate under nitrogen gas. 
According to the final concentration of your samples, add certain amount of 
chloroform if needed. 
8) Transfer it to GC-MS vial 
9) Set up the GC-MS equipment as follows: the helium (He) gas flow rate is set at 0.5 
ml/min. The oven temperature profile programming is set as follows 
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 Temperature Duration 
Initial temperature 70 °C Holds for 2 minutes 
Ramp at 10°C/min 150 °C Holds for 3 minutes 
Ramp at 10°C/min 260 °C Holds for 3 minutes 
38 minutes are needed for one sample analysis. 
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7.3 Media composition detail for both MOPs and M9 minimum media 
Table 5 Chemical compositions of M9 media 
Chemicals Content 
5X M9 salt which contains 200ml 
Na2HPO4.7H2O in 5X M9 salt 64g 
KH2PO4 in 5X M9 salt 15g 
NaCl in 5X M9 salt 2.5g 
NH4Cl in 5X M9 salt 4.0g 
1M MgSO4  2ml 
1M CaCl2 100ul 
1mg/L Thiamine-HCL 1ml 
Trace element solutions 10ml 
FeCl3.6H20 in 500 ml of trace element solutions 16.67g 
ZnSO4.7H2O 500 ml of trace element solutions 0.18 
CuCl2.2H2O 500ml of trace element solutions 0.12g 
MnSO4.H2O 500 ml of trace element solutions 0.12g 
CoCl2.6H2O 500 ml of trace element solutions 0.18g 
Na2EDTA.2H2O 500 ml of trace element solutions 22.25g 
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Table 6 Chemical compositions of MOPs media 
Chemicals Content 
40-X stock solution 25ml 
0.528M/L MgCl2 1ml 
0.276M/L K2SO4 1ml 
1M/L K2HPO4 2ml 
40-X ‘Mops’ 1L Which contains 
MOPS powder (sigma) 334.8g 
Tricine(Sigma) 28.8 g 
NaCl 116.8g 
NH4Cl 20.4g 
KOH 64.0g 
Micronutrient solution 2.0ml 
Which contains 100ml of the micronutrient 
solution 
FeCl2.4H2O  5g/100ml 
CaCl2.2H2O 184mg/100ml 
H3BO3 62mg/100ml 
MnCl2. 4H2O 40mg/100ml 
CoCl2. 6H2O 18mg/100ml 
CuCl2. 2H2O 4mg/100ml 
37% HCL 8ml/100ml  
Add each of the following 0.2ml 
Na2SeO3 430mg/10ml 
Na2MoO4 605mg/10ml 
ZnCl2 340mg/10ml 
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7.4 Biomass composition 
Table 7 Requirement of metabolite precursors for biosynthesis of building blocks in Model 1 
Precursor metabolites Amount required 
mmol/g cell 
G6P 0.205 
F6P 0.071 
R5P 0.898 
E4P 0.361 
T3P 0.129 
PEP 0.519 
PYR 2.431 
ACCOA 3.748 
AKG 1.079 
OAA 1.787 
3PG 1.496 
Table 8 Requirement of metabolite precursors for biosynthesis of building blocks in Model 2 
Precursor metabolites Amount required 
mmol/g cell 
G6P 0.205 
F6P 0.0709 
R5P 0.8977 
E4P 0.361 
T3P 0.129 
PEP 0.5191 
PYR 1.9428 
ACCOA 3.7478 
AKG 0.0879 
OAA 1.3167 
3PG 0.5315 
C1 0.0485 
Ser 0.334 
Gly 0.582 
Thr 0.241 
Glut 0.25 
Gln 0.25 
Ala 0.488 
Asp 0.229 
Arg 0.281 
Pro 0.21 
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7.5 Sample calculation for yield and specific rate  
In this Appendix, the glucose specific uptake rate is calculated. The fermentation is 
conducted in aerobic condition with DO (dissolved oxygen) level above 50% of saturated 
concentration. The biomass concentration was monitored by measuring OD550 during 
exponential phase, and the glucose concentration is measured by HPLC. The Figure 32 
shows the plot of X (biomass molar concentration) versus S (glucose molar concentration) 
during exponential phase. 
 
Figure 35 Biomass molar concentration change with substrate (glucose) during exponential phase for one replicate. 
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 With the quasi-steady state assumption, the specific glucose uptake rate (
1
X
dS
dt
) is 
constant during exponential phase. As we known
1 1dS dS dX dS
X dt dX X dt dX
  , growth rate is 
a constant, 
dS
dX
 should be a constant. 
After obtaining the slope of S and X, the specific glucose uptake rate can be 
calculated by
1 1dS dS dX dS
X dt dX X dt dX
  .  
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7.6 Results for quantitative physiological state description for all three biological replicates 
Table 9 details for physiological state for each set of biological replicate, and the result for one tail T test is included. The differences are significant between control 
and C8 stress with the criteria of P value <0.05. 
Culture 
condition 
  Growth rate  Biomass yield  Acetate yield  
Specific uptake 
rate of glucose  
Specific production 
rate of acetate  
  hr
-1
 
mol biomass/mol 
glucose  
mol acetate/mol 
glucose 
mmol/g. 
CDW.hr 
mmol/g.CDW.hr 
Control R1 0.7744 2.3681 0.2634 13.0284 3.4317 
  R2 0.7757 2.7962 0.4909 11.0523 5.4256 
  R3 0.7229 2.7998 0.4463 10.2867 4.5910 
C8 stress R1 0.4615 1.9447 0.6636 9.4546 6.2741 
 
R2 0.4176 1.7295 0.6203 9.6198 5.9672 
  R3 0.2441 1.5148 0.8986 6.4201 5.7691 
P value  0.0025 0.0041 0.0210 0.0445 0.0317 
Significant   Y Y Y Y Y 
 
Note: the ‘R1, R2, R3’ represents biological replicate 1, biological replicate 2, and biological replicate 3 respectively. 
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7.7 Results amino acids isotopomer measurement for all three biological replicates 
Table 10 Isotopomer patern for amino acids in three biological relicates. ‘R1’ means biological replicate 1, the data for control and C8 stress are shown in groups. 
Precursor 
Amino 
acids 
Peak 
types 
Isotopomer of carbon backbone in 
amino acids 
Isotopomer of carbon backbone in the precursor Control R1 35 mM C8 R1 
Relative 
intensity 
Noise 
Relative 
intensity 
Noise 
3PG Ser_2 s [123] [123] 0.0043 0.0200 0.0017 0.0200 
  Ser_2 d1 [123] [123] 0.1407 0.0200 0.3932 0.0200 
  Ser_2 d2 [123] [123] 0.1085 0.0200 0.1262 0.0200 
  Ser_2 dd [123] [123] 0.7465 0.0200 0.479 0.0200 
  Ser_3 s [x23] [x23] 0.4650 0.0095 0.5370 0.0110 
  Ser_3 d [x23] [x23] 0.5350 0.0095 0.4630 0.0110 
AKG Glu_3 s [x234x] [x234x] 0.2044 0.0074 0.2992 0.0093 
  Glu_3 d [x234x]+[x234x] [x234x]+[x234x] 0.5644 0.0074 0.5073 0.0093 
  Glu_3 t [x234x] [x234x] 0.2311 0.0074 0.1935 0.0093 
  Glu_4 s [xx345] [xx345] 0.1828 0.0200 0.2854 0.0200 
  Glu_4 d1 [xx345] [xx345] 0.0643 0.0200 0.0841 0.0200 
  Glu_4 d2 [xx345] [xx345] 0.5493 0.0200 0.4601 0.0200 
  Glu_4 dd [xx345] [xx345] 0.2036 0.0200 0.1705 0.0200 
OAA Asp_2 s [123x] [123x] 0.2819 0.0200 0.2496 0.0500 
  Asp_2 d1 [123x] [123x] 0.2260 0.0200 0.3395 0.0500 
  Asp_2 d2 [123x] [123x] 0.0757 0.0200 0.1354 0.0500 
  Asp_2 dd [123x] [123x] 0.4164 0.0200 0.2755 0.0500 
  Asp_3 s [x234] [x234] 0.2070 0.0200 0.2343 0.0500 
  Asp_3 d1 [x234] [x234] 0.3460 0.0200 0.2490 0.0500 
  Asp_3 d2 [x234] [x234] 0.1169 0.0200 0.1511 0.0500 
  Asp_3 dd [x234] [x234] 0.3301 0.0200 0.3656 0.0500 
  Thr_3 s [x234] [x234] 0.1756 0.0056 0.2213 0.0078 
  Thr_3 d [x234]+[x234] [x234]+[x234] 0.4861 0.0056 0.5442 0.0078 
  Thr_3 t [x234] [x234] 0.3383 0.0056 0.2344 0.0078 
  Thr_4 s [xx34] [xx34] 0.3856 0.0142 0.3875 0.0267 
  Thr_4 d [xx34] [xx34] 0.6144 0.0142 0.6125 0.0267 
  Ile_5 s [xxx45x] [xx34] 0.4278 0.0209 0.4210 0.0479 
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  Ile_5 d [xxx45x] [xx34] 0.5722 0.0209 0.5790 0.0479 
PEP Tyr_2 s [123xxxxxx] [123] 0.0072 0.0200 0.0001 0.0200 
  Tyr_2 d1 [123xxxxxx] [123] 0.0090 0.0200 0.0001 0.0200 
  Tyr_2 d2 [123xxxxxx] [123] 0.2226 0.0200 0.0925 0.0200 
  Tyr_2 dd [123xxxxxx] [123] 0.7613 0.0200 0.9073 0.0200 
  Tyr_3 s [x234xxxxx] [x23].[x2x] 0.2157 0.0100 0.2157 0.0100 
  Tyr_3 d [x234xxxxx]+[x234xxxxx] [x23].[x2x]+[x23].[x2x] 0.5658 0.0100 0.5658 0.0100 
  Tyr_3 t [x234xxxxx] [x23].[x2x] 0.2186 0.0100 0.2186 0.0100 
  Phe_2 s [123xxxxxx] [123] 0.0436 0.0200 0.0356 0.0200 
  Phe_2 d1 [123xxxxxx] [123] 0.0091 0.0200 0.0168 0.0200 
  Phe_2 d2 [123xxxxxx] [123] 0.1549 0.0200 0.1441 0.0200 
  Phe_2 dd [123xxxxxx] [123] 0.7924 0.0200 0.8035 0.0200 
  Phe_3 s [x234xxxxx] [x23].[x2x] 0.2208 0.0200 0.1683 0.0200 
  Phe_3 d1 [x234xxxxx] [x23].[x2x] 0.5895 0.0200 0.6390 0.0200 
  Phe_3 d2 [x234xxxxx] [x23].[x2x] 0.0000 0.0200 0.0000 0.0200 
  Phe_3 dd [x234xxxxx] [x23].[x2x] 0.1897 0.0200 0.1927 0.0200 
PYR Ala_2 s [123] [123] 0.0473 0.0200 0.0066 0.0200 
  Ala_2 d1 [123] [123] 0.0577 0.0200 0.0013 0.0200 
  Ala_2 d2 [123] [123] 0.1168 0.0200 0.2195 0.0200 
  Ala_2 dd [123] [123] 0.7801 0.0200 0.7727 0.0200 
  Ala_3 s [x23] [x23] 0.3358 0.0090 0.3569 0.0081 
  Ala_3 d [x23] [x23] 0.6642 0.0090 0.6431 0.0081 
  Val_2 s [123xx] [12x].[x2x] 0.0665 0.0200 0.0981 0.0200 
  Val_2 d1 [123xx] [12x].[x2x] 0.6408 0.0200 0.6571 0.0200 
  Val_2 d2 [123xx] [12x].[x2x] 0.0415 0.0200 0.0460 0.0200 
  Val_2 dd [123xx] [12x].[x2x] 0.2513 0.0200 0.1988 0.0200 
  Val_4 s [xx34x] [x23] 0.2842 0.0183 0.3485 0.0261 
  Val_4 d [xx34x] [x23] 0.7158 0.0183 0.6515 0.0261 
  Val_5 s [xx3x5] [xx3].[xx2] 0.7586 0.0156 0.7088 0.0106 
  Val_5 d [xx3x5] [xx3].[xx2] 0.2414 0.0156 0.2912 0.0106 
  Leu_5 s [xxx45x] [x23] 0.4396 0.0185 0.4513 0.0200 
  Leu_5 d [xxx45x] [x23] 0.5604 0.0185 0.5487 0.0225 
  Leu_6 s [xxx4x6] [xx3].[xx2] 0.7897 0.0163 0.7726 0.0314 
  Leu_6 d [xxx4x6] [xx3].[xx2] 0.2103 0.0163 0.2274 0.0314 
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  Ile_6 s [xx3xx6] [x23] 0.3350 0.0198 0.3429 0.0165 
  Ile_6 d [xx3xx6] [x23] 0.6650 0.0198 0.6571 0.0165 
R5P His_3 s [x234x] [xx345] 0.0714 0.0200 0.0736 0.0200 
  His_3 d1 [x234x] [xx345] 0.4214 0.0200 0.5085 0.0200 
  His_3 d2 [x234x] [xx345] 0.0284 0.0200 0.0186 0.0200 
  His_3 dd [x234x] [xx345] 0.4788 0.0200 0.3993 0.0200 
Glut Arg_3 s [x234x] [x234x] 0.2346 0.0207 0.3261 0.0147 
  Arg_3 d [x234x]+[x234x] [x234x]+[x234x] 0.5298 0.0207 0.4743 0.0147 
  Arg_3 t [x234x] [x234x] 0.2356 0.0207 0.1996 0.0147 
  Arg_5 s [xxx45] [xxx45] 0.0930 0.0193 0.0975 0.0659 
  Arg_5 d [xxx45] [xxx45] 0.9070 0.0193 0.9025 0.0659 
  Pro_3 s [x234x] [x234x] 0.1775 0.0085 0.2574 0.0084 
  Pro_3 d [x234x]+[x234x] [x234x]+[x234x] 0.5285 0.0085 0.5078 0.0084 
  Pro_3 t [x234x] [x234x] 0.2940 0.0085 0.2348 0.0084 
  Pro_4 s [xx345] [xx345] 0.1480 0.0145 0.1638 0.0146 
  Pro_4 d [xx345]+[xx345] [xx345]+[xx345] 0.5812 0.0145 0.5634 0.0146 
  Pro_4 t [xx345] [xx345] 0.2707 0.0145 0.2728 0.0146 
  Pro_5 s [xxx45] [xxx45] 0.2012 0.0176 0.2087 0.0227 
  Pro_5 d [xxx45] [xxx45] 0.7988 0.0176 0.7913 0.0227 
Ser Gly_2 s [12] [12x] 0.1099 0.0211 0.1362 0.0081 
  Gly_2 d [12] [12x] 0.8901 0.0211 0.8638 0.0081 
AcCOA/PYR Leu_2 s [123xxx] [12].[x2x] 0.3269 0.0200 0.3206 0.0200 
  Leu_2 d1 [123xxx] [12].[x2x] 0.5060 0.0200 0.5453 0.0200 
  Leu_2 d2 [123xxx] [12].[x2x] 0.0931 0.0200 0.0611 0.0200 
  Leu_2 dd [123xxx] [12].[x2x] 0.0740 0.0200 0.0730 0.0200 
  Leu_3 s [x234xx] [x2].[x2x].[x2x] 0.4712 0.0057 0.4766 0.0128 
  Leu_3 d [x234xx]+[x234xx] [x2].[x2x].[x2x]+[x2].[x2x].[x2x] 0.4046 0.0057 0.3880 0.0128 
  Leu_3 t [x234xx] [x2].[x2x].[x2x] 0.1242 0.0057 0.1354 0.0128 
OAA/PYR Ile_2 s [123xxx] [12xx].[x2x] 0.2934 0.0200 0.4602 0.0200 
  Ile_2 d1 [123xxx] [12xx].[x2x] 0.5295 0.0200 0.4194 0.0200 
  Ile_2 d2 [123xxx] [12xx].[x2x] 0.1035 0.0200 0.0517 0.0200 
  Ile_2 dd [123xxx] [12xx].[x2x] 0.0737 0.0200 0.0687 0.0200 
  Ile_3 s [x234xx] [x23x].[x2x] 0.0306 0.0103 0.0225 0.0176 
  Ile_3 d [x234xx]+[x234xx] [x23x].[x2x]+[x23x].[x2x] 0.7444 0.0103 0.6534 0.0176 
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  Ile_3 t [x234xx] [x23x].[x2x] 0.2250 0.0103 0.3240 0.0176 
  Ile_4 s [xx345x] [xx34].[x2x] 0.3241 0.0129 0.3608 0.0126 
  Ile_4 d [xx345x]+[xx345x] [xx34].[x2x]+[xx34].[x2x] 0.5178 0.0129 0.5027 0.0126 
  Ile_4 t [xx345x] [xx34].[x2x] 0.1581 0.0129 0.1366 0.0126 
  Lys_3 s [x234xx] 0.5{[x234]+[x23].[xxx4]} 0.1878 0.0045 0.1962 0.0698 
  Lys_3 d [x234xx]+[x234xx] 0.5{[x234]+[x23].[xxx4]+[x234]+[x23].[xxx4]} 0.5514 0.0045 0.5341 0.0698 
  Lys_3 t [x234xx] 0.5{[x234]+[x23].[xxx4]} 0.2608 0.0045 0.2697 0.0698 
  Lys_4 s [xx345x] [xx34].[xx3] 0.2027 0.0216 0.1490 0.0286 
  Lys_4 d [xx345x]+[xx345x] [xx34].[xx3]+[xx34].[xx3] 0.5632 0.0216 0.5279 0.0286 
  Lys_4 t [xx345x] [xx34].[xx3] 0.2341 0.0216 0.3231 0.0286 
  Lys_5 s [xxx456] 0.5{[x234]+[x23].[xxx4]} 0.1836 0.0073 0.2048 0.0200 
  Lys_5 d [xxx456]+[xxx456] 0.5{[x234]+[x23].[xxx4]+[x234]+[x23].[xxx4]} 0.5154 0.0073 0.5306 0.0200 
  Lys_5 t [xxx456] 0.5{[x234]+[x23].[xxx4]} 0.3010 0.0073 0.2647 0.0200 
Table 11 Isotopomer patern for amino acids in three biological relicates. ‘R2’ means biological replicate 2 the data for control and C8 stress are shown in groups 
Precursor 
Amino 
acids 
Peak 
types 
Isotopomer of carbon backbone in 
amino acids 
Isotopomer of carbon backbone in the precursor Control R2 35 mM C8 R2 
Relative 
intensity 
Noise 
Relative 
intensity 
Noise 
3PG Ser_2 s [123] [123] 0.0226 0.0200 0.0155 0.0200 
  Ser_2 d1 [123] [123] 0.025 0.0200 0.144 0.0200 
  Ser_2 d2 [123] [123] 0.1431 0.0200 0.0412 0.0200 
  Ser_2 dd [123] [123] 0.8093 0.0200 0.7993 0.0200 
  Ser_3 s [x23] [x23] 0.4687 0.0095 0.5094 0.0110 
  Ser_3 d [x23] [x23] 0.5313 0.0095 0.4906 0.0110 
AKG Glu_3 s [x234x] [x234x] 0.2091 0.0074 0.2900 0.0093 
  Glu_3 d [x234x]+[x234x] [x234x]+[x234x] 0.5565 0.0074 0.5042 0.0093 
  Glu_3 t [x234x] [x234x] 0.2344 0.0074 0.2058 0.0093 
  Glu_4 s [xx345] [xx345] 0.2754 0.0200 0.2852 0.0200 
  Glu_4 d1 [xx345] [xx345] 0.0662 0.0200 0.0459 0.0200 
  Glu_4 d2 [xx345] [xx345] 0.5191 0.0200 0.4824 0.0200 
  Glu_4 dd [xx345] [xx345] 0.1393 0.0200 0.1856 0.0200 
OAA Asp_2 s [123x] [123x] 0.2585 0.0200 0.2429 0.0500 
  Asp_2 d1 [123x] [123x] 0.2579 0.0200 0.2508 0.0500 
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  Asp_2 d2 [123x] [123x] 0.1014 0.0200 0.1544 0.0500 
  Asp_2 dd [123x] [123x] 0.3822 0.0200 0.3519 0.0500 
  Asp_3 s [x234] [x234] 0.1925 0.0200 0.2854 0.0500 
  Asp_3 d1 [x234] [x234] 0.2560 0.0200 0.3999 0.0500 
  Asp_3 d2 [x234] [x234] 0.1840 0.0200 0.1680 0.0500 
  Asp_3 dd [x234] [x234] 0.3674 0.0200 0.1467 0.0500 
  Thr_3 s [x234] [x234] 0.1784 0.0056 0.1756 0.0078 
  Thr_3 d [x234]+[x234] [x234]+[x234] 0.4998 0.0056 0.4861 0.0078 
  Thr_3 t [x234] [x234] 0.3218 0.0056 0.3383 0.0078 
  Thr_4 s [xx34] [xx34] 0.4149 0.0142 0.4217 0.0267 
  Thr_4 d [xx34] [xx34] 0.5851 0.0142 0.5783 0.0267 
  Ile_5 s [xxx45x] [xx34] 0.4406 0.0209 0.3999 0.0479 
  Ile_5 d [xxx45x] [xx34] 0.5594 0.0209 0.6001 0.0479 
PEP Tyr_2 s [123xxxxxx] [123] 0.0361 0.0200 0.0188 0.0200 
  Tyr_2 d1 [123xxxxxx] [123] 0.0217 0.0200 0.0087 0.0200 
  Tyr_2 d2 [123xxxxxx] [123] 0.0466 0.0200 0.0762 0.0200 
  Tyr_2 dd [123xxxxxx] [123] 0.8956 0.0200 0.8962 0.0200 
  Tyr_3 s [x234xxxxx] [x23].[x2x] 0.2407 0.0100 0.2191 0.0100 
  Tyr_3 d [x234xxxxx]+[x234xxxxx] [x23].[x2x]+[x23].[x2x] 0.5749 0.0100 0.5795 0.0100 
  Tyr_3 t [x234xxxxx] [x23].[x2x] 0.1843 0.0100 0.2015 0.0100 
  Phe_2 s [123xxxxxx] [123] 0.0206 0.0200 0.0926 0.0200 
  Phe_2 d1 [123xxxxxx] [123] 0.0326 0.0200 0.0016 0.0200 
  Phe_2 d2 [123xxxxxx] [123] 0.0795 0.0200 0.1227 0.0200 
  Phe_2 dd [123xxxxxx] [123] 0.8673 0.0200 0.7831 0.0200 
  Phe_3 s [x234xxxxx] [x23].[x2x] 0.1889 0.0200 0.1822 0.0200 
  Phe_3 d1 [x234xxxxx] [x23].[x2x] 0.5711 0.0200 0.5645 0.0200 
  Phe_3 d2 [x234xxxxx] [x23].[x2x] 0.0272 0.0200 0.0572 0.0200 
  Phe_3 dd [x234xxxxx] [x23].[x2x] 0.2127 0.0200 0.1961 0.0200 
PYR Ala_2 s [123] [123] 0.0208 0.0200 0.0351 0.0200 
  Ala_2 d1 [123] [123] 0.0384 0.0200 0.0272 0.0200 
  Ala_2 d2 [123] [123] 0.3505 0.0200 0.0657 0.0200 
  Ala_2 dd [123] [123] 0.5903 0.0200 0.8719 0.0200 
  Ala_3 s [x23] [x23] 0.3531 0.0090 0.3558 0.0081 
  Ala_3 d [x23] [x23] 0.6469 0.0090 0.6442 0.0081 
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  Val_2 s [123xx] [12x].[x2x] 0.0928 0.0200 0.0782 0.0200 
  Val_2 d1 [123xx] [12x].[x2x] 0.4988 0.0200 0.7005 0.0200 
  Val_2 d2 [123xx] [12x].[x2x] 0.0152 0.0200 0.0649 0.0200 
  Val_2 dd [123xx] [12x].[x2x] 0.3932 0.0200 0.1564 0.0200 
  Val_4 s [xx34x] [x23] 0.3092 0.0183 0.3376 0.0261 
  Val_4 d [xx34x] [x23] 0.6908 0.0183 0.6624 0.0261 
  Val_5 s [xx3x5] [xx3].[xx2] 0.7593 0.0156 0.7606 0.0106 
  Val_5 d [xx3x5] [xx3].[xx2] 0.2407 0.0156 0.2394 0.0106 
  Leu_5 s [xxx45x] [x23] 0.4162 0.0185 0.4389 0.0200 
  Leu_5 d [xxx45x] [x23] 0.5838 0.0185 0.5611 0.0225 
  Leu_6 s [xxx4x6] [xx3].[xx2] 0.7865 0.0163 0.7470 0.0314 
  Leu_6 d [xxx4x6] [xx3].[xx2] 0.2135 0.0163 0.2530 0.0314 
  Ile_6 s [xx3xx6] [x23] 0.3286 0.0198 0.3474 0.0165 
  Ile_6 d [xx3xx6] [x23] 0.6714 0.0198 0.6526 0.0165 
R5P His_3 s [x234x] [xx345] 0.0909 0.0200 0.0719 0.0200 
  His_3 d1 [x234x] [xx345] 0.481 0.0200 0.6106 0.0200 
  His_3 d2 [x234x] [xx345] 0.0176 0.0200 0.0258 0.0200 
  His_3 dd [x234x] [xx345] 0.4105 0.0200 0.2917 0.0200 
Glut Arg_3 s [x234x] [x234x] 0.2368 0.0207 0.3364 0.0147 
  Arg_3 d [x234x]+[x234x] [x234x]+[x234x] 0.5319 0.0207 0.4730 0.0147 
  Arg_3 t [x234x] [x234x] 0.2313 0.0207 0.1906 0.0147 
  Arg_5 s [xxx45] [xxx45] 0.0858 0.0193 0.1006 0.0659 
  Arg_5 d [xxx45] [xxx45] 0.9142 0.0193 0.8994 0.0659 
  Pro_3 s [x234x] [x234x] 0.1807 0.0085 0.1993 0.0084 
  Pro_3 d [x234x]+[x234x] [x234x]+[x234x] 0.5326 0.0085 0.5240 0.0084 
  Pro_3 t [x234x] [x234x] 0.2867 0.0085 0.2767 0.0084 
  Pro_4 s [xx345] [xx345] 0.1493 0.0145 0.1699 0.0146 
  Pro_4 d [xx345]+[xx345] [xx345]+[xx345] 0.5725 0.0145 0.5573 0.0146 
  Pro_4 t [xx345] [xx345] 0.2782 0.0145 0.2728 0.0146 
  Pro_5 s [xxx45] [xxx45] 0.2208 0.0176 0.2525 0.0227 
  Pro_5 d [xxx45] [xxx45] 0.7792 0.0176 0.7475 0.0227 
Ser Gly_2 s [12] [12x] 0.1265 0.0211 0.1497 0.0081 
  Gly_2 d [12] [12x] 0.8735 0.0211 0.8503 0.0081 
AcCOA/PYR Leu_2 s [123xxx] [12].[x2x] 0.3041 0.0200 0.2628 0.0200 
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  Leu_2 d1 [123xxx] [12].[x2x] 0.5216 0.0200 0.5250 0.0200 
  Leu_2 d2 [123xxx] [12].[x2x] 0.0418 0.0200 0.0463 0.0200 
  Leu_2 dd [123xxx] [12].[x2x] 0.1325 0.0200 0.1660 0.0200 
  Leu_3 s [x234xx] [x2].[x2x].[x2x] 0.4874 0.0057 0.4723 0.0128 
  Leu_3 d [x234xx]+[x234xx] [x2].[x2x].[x2x]+[x2].[x2x].[x2x] 0.3923 0.0057 0.3957 0.0128 
  Leu_3 t [x234xx] [x2].[x2x].[x2x] 0.1203 0.0057 0.1319 0.0128 
OAA/PYR Ile_2 s [123xxx] [12xx].[x2x] 0.3260 0.0200 0.2898 0.0200 
  Ile_2 d1 [123xxx] [12xx].[x2x] 0.4748 0.0200 0.5457 0.0200 
  Ile_2 d2 [123xxx] [12xx].[x2x] 0.0833 0.0200 0.0759 0.0200 
  Ile_2 dd [123xxx] [12xx].[x2x] 0.1159 0.0200 0.0886 0.0200 
  Ile_3 s [x234xx] [x23x].[x2x] 0.0256 0.0103 0.0277 0.0176 
  Ile_3 d [x234xx]+[x234xx] [x23x].[x2x]+[x23x].[x2x] 0.7501 0.0103 0.6539 0.0176 
  Ile_3 t [x234xx] [x23x].[x2x] 0.2243 0.0103 0.3184 0.0176 
  Ile_4 s [xx345x] [xx34].[x2x] 0.3595 0.0129 0.3368 0.0126 
  Ile_4 d [xx345x]+[xx345x] [xx34].[x2x]+[xx34].[x2x] 0.4987 0.0129 0.5113 0.0126 
  Ile_4 t [xx345x] [xx34].[x2x] 0.1418 0.0129 0.1519 0.0126 
  Lys_3 s [x234xx] 0.5{[x234]+[x23].[xxx4]} 0.1975 0.0045 0.2240 0.0698 
  Lys_3 d [x234xx]+[x234xx] 0.5{[x234]+[x23].[xxx4]+[x234]+[x23].[xxx4]} 0.5419 0.0045 0.5396 0.0698 
  Lys_3 t [x234xx] 0.5{[x234]+[x23].[xxx4]} 0.2607 0.0045 0.2363 0.0698 
  Lys_4 s [xx345x] [xx34].[xx3] 0.2380 0.0216 0.1715 0.0286 
  Lys_4 d [xx345x]+[xx345x] [xx34].[xx3]+[xx34].[xx3] 0.5324 0.0216 0.5148 0.0286 
  Lys_4 t [xx345x] [xx34].[xx3] 0.2296 0.0216 0.3137 0.0286 
  Lys_5 s [xxx456] 0.5{[x234]+[x23].[xxx4]} 0.1973 0.0073 0.2067 0.0200 
  Lys_5 d [xxx456]+[xxx456] 0.5{[x234]+[x23].[xxx4]+[x234]+[x23].[xxx4]} 0.5130 0.0073 0.5258 0.0200 
  Lys_5 t [xxx456] 0.5{[x234]+[x23].[xxx4]} 0.2897 0.0073 0.2675 0.0200 
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Table 12 Isotopomer patern for amino acids in three biological relicates. ‘R3’ means biological replicate 3 the data for control and C8 stress are shown in groups 
Precursor 
Amino 
acids 
Peak 
types 
Isotopomer of carbon backbone in 
amino acids 
Isotopomer of carbon backbone in the precursor Control R3 35 mM C8 R3 
Relative 
intensity 
Noise 
Relative 
intensity 
Noise 
3PG Ser_2 s [123] [123] 0.0187 0.0200 0.0626 0.0200 
  Ser_2 d1 [123] [123] 0.0960 0.0200 0.2515 0.0200 
  Ser_2 d2 [123] [123] 0.0148 0.0200 0.305 0.0200 
  Ser_2 dd [123] [123] 0.8705 0.0200 0.3819 0.0200 
  Ser_3 s [x23] [x23] 0.4623 0.0095 0.5776 0.0110 
  Ser_3 d [x23] [x23] 0.5377 0.0095 0.4224 0.0110 
AKG Glu_3 s [x234x] [x234x] 0.1930 0.0074 0.3214 0.0093 
  Glu_3 d [x234x]+[x234x] [x234x]+[x234x] 0.5624 0.0074 0.4947 0.0093 
  Glu_3 t [x234x] [x234x] 0.2446 0.0074 0.1839 0.0093 
  Glu_4 s [xx345] [xx345] 0.2284 0.0200 0.269 0.0200 
  Glu_4 d1 [xx345] [xx345] 0.0554 0.0200 0.0532 0.0200 
  Glu_4 d2 [xx345] [xx345] 0.521 0.0200 0.491 0.0200 
  Glu_4 dd [xx345] [xx345] 0.1952 0.0200 0.1868 0.0200 
OAA Asp_2 s [123x] [123x] 0.2560 0.0200 0.2836 0.0500 
  Asp_2 d1 [123x] [123x] 0.2109 0.0200 0.3123 0.0500 
  Asp_2 d2 [123x] [123x] 0.0904 0.0200 0.1940 0.0500 
  Asp_2 dd [123x] [123x] 0.4427 0.0200 0.2101 0.0500 
  Asp_3 s [x234] [x234] 0.2199 0.0200 0.2312 0.0500 
  Asp_3 d1 [x234] [x234] 0.3018 0.0200 0.3929 0.0500 
  Asp_3 d2 [x234] [x234] 0.2478 0.0200 0.2212 0.0500 
  Asp_3 dd [x234] [x234] 0.2305 0.0200 0.1547 0.0500 
  Thr_3 s [x234] [x234] 0.1668 0.0056 0.2541 0.0078 
  Thr_3 d [x234]+[x234] [x234]+[x234] 0.5023 0.0056 0.5185 0.0078 
  Thr_3 t [x234] [x234] 0.3309 0.0056 0.2274 0.0078 
  Thr_4 s [xx34] [xx34] 0.4307 0.0142 0.4157 0.0267 
  Thr_4 d [xx34] [xx34] 0.5693 0.0142 0.5843 0.0267 
  Ile_5 s [xxx45x] [xx34] 0.4485 0.0209 0.4026 0.0479 
  Ile_5 d [xxx45x] [xx34] 0.5515 0.0209 0.5974 0.0479 
PEP Tyr_2 s [123xxxxxx] [123] 0.0547 0.0200 0.009 0.0200 
  Tyr_2 d1 [123xxxxxx] [123] 0.0246 0.0200 0.0072 0.0200 
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  Tyr_2 d2 [123xxxxxx] [123] 0.0793 0.0200 0.0952 0.0200 
  Tyr_2 dd [123xxxxxx] [123] 0.8414 0.0200 0.8886 0.0200 
  Tyr_3 s [x234xxxxx] [x23].[x2x] 0.2353 0.0100 0.2332 0.0100 
  Tyr_3 d [x234xxxxx]+[x234xxxxx] [x23].[x2x]+[x23].[x2x] 0.5831 0.0100 0.5757 0.0100 
  Tyr_3 t [x234xxxxx] [x23].[x2x] 0.1815 0.0100 0.1910 0.0100 
  Phe_2 s [123xxxxxx] [123] 0.0531 0.0200 0.0531 0.0200 
  Phe_2 d1 [123xxxxxx] [123] 0.0014 0.0200 0.0014 0.0200 
  Phe_2 d2 [123xxxxxx] [123] 0.1059 0.0200 0.1059 0.0200 
  Phe_2 dd [123xxxxxx] [123] 0.8396 0.0200 0.8396 0.0200 
  Phe_3 s [x234xxxxx] [x23].[x2x] 0.2050 0.0200 0.2239 0.0200 
  Phe_3 d1 [x234xxxxx] [x23].[x2x] 0.5173 0.0200 0.5053 0.0200 
  Phe_3 d2 [x234xxxxx] [x23].[x2x] 0.1390 0.0200 0.0512 0.0200 
  Phe_3 dd [x234xxxxx] [x23].[x2x] 0.1388 0.0200 0.2197 0.0200 
PYR Ala_2 s [123] [123] 0.0422 0.0200 0.0993 0.0200 
  Ala_2 d1 [123] [123] 0.027 0.0200 0.0283 0.0200 
  Ala_2 d2 [123] [123] 0.1492 0.0200 0.0705 0.0200 
  Ala_2 dd [123] [123] 0.7796 0.0200 0.802 0.0200 
  Ala_3 s [x23] [x23] 0.3504 0.0090 0.3694 0.0081 
  Ala_3 d [x23] [x23] 0.6496 0.0090 0.6306 0.0081 
  Val_2 s [123xx] [12x].[x2x] 0.0693 0.0200 0.0795 0.0200 
  Val_2 d1 [123xx] [12x].[x2x] 0.6706 0.0200 0.5153 0.0200 
  Val_2 d2 [123xx] [12x].[x2x] 0.0461 0.0200 0.0323 0.0200 
  Val_2 dd [123xx] [12x].[x2x] 0.2141 0.0200 0.3729 0.0200 
  Val_4 s [xx34x] [x23] 0.3274 0.0183 0.3418 0.0261 
  Val_4 d [xx34x] [x23] 0.6726 0.0183 0.6582 0.0261 
  Val_5 s [xx3x5] [xx3].[xx2] 0.7505 0.0156 0.7566 0.0106 
  Val_5 d [xx3x5] [xx3].[xx2] 0.2495 0.0156 0.2434 0.0106 
  Leu_5 s [xxx45x] [x23] 0.4011 0.0185 0.4517 0.0200 
  Leu_5 d [xxx45x] [x23] 0.5989 0.0185 0.5483 0.0225 
  Leu_6 s [xxx4x6] [xx3].[xx2] 0.7668 0.0163 0.7582 0.0314 
  Leu_6 d [xxx4x6] [xx3].[xx2] 0.2332 0.0163 0.2418 0.0314 
  Ile_6 s [xx3xx6] [x23] 0.3274 0.0198 0.4026 0.0165 
  Ile_6 d [xx3xx6] [x23] 0.6726 0.0198 0.5974 0.0165 
R5P His_3 s [x234x] [xx345] 0.093 0.0200 0.0475 0.0200 
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  His_3 d1 [x234x] [xx345] 0.4556 0.0200 0.6444 0.0200 
  His_3 d2 [x234x] [xx345] 0.0265 0.0200 0.0222 0.0200 
  His_3 dd [x234x] [xx345] 0.425 0.0200 0.286 0.0200 
Glut Arg_3 s [x234x] [x234x] 0.2531 0.0207 0.3459 0.0147 
  Arg_3 d [x234x]+[x234x] [x234x]+[x234x] 0.5279 0.0207 0.4740 0.0147 
  Arg_3 t [x234x] [x234x] 0.2191 0.0207 0.1802 0.0147 
  Arg_5 s [xxx45] [xxx45] 0.0895 0.0193 0.0989 0.0659 
  Arg_5 d [xxx45] [xxx45] 0.9105 0.0193 0.9011 0.0659 
  Pro_3 s [x234x] [x234x] 0.1650 0.0085 0.2685 0.0084 
  Pro_3 d [x234x]+[x234x] [x234x]+[x234x] 0.5482 0.0085 0.5091 0.0084 
  Pro_3 t [x234x] [x234x] 0.2868 0.0085 0.2224 0.0084 
  Pro_4 s [xx345] [xx345] 0.1496 0.0145 0.1652 0.0146 
  Pro_4 d [xx345]+[xx345] [xx345]+[xx345] 0.5649 0.0145 0.5539 0.0146 
  Pro_4 t [xx345] [xx345] 0.2855 0.0145 0.2809 0.0146 
  Pro_5 s [xxx45] [xxx45] 0.2402 0.0176 0.2452 0.0227 
  Pro_5 d [xxx45] [xxx45] 0.7598 0.0176 0.7548 0.0227 
Ser Gly_2 s [12] [12x] 0.1383 0.0211 0.1515 0.0081 
  Gly_2 d [12] [12x] 0.8617 0.0211 0.8485 0.0081 
AcCOA/PYR Leu_2 s [123xxx] [12].[x2x] 0.2507 0.0200 0.2169 0.0200 
  Leu_2 d1 [123xxx] [12].[x2x] 0.5550 0.0200 0.4065 0.0200 
  Leu_2 d2 [123xxx] [12].[x2x] 0.0441 0.0200 0.2018 0.0200 
  Leu_2 dd [123xxx] [12].[x2x] 0.1501 0.0200 0.1748 0.0200 
  Leu_3 s [x234xx] [x2].[x2x].[x2x] 0.4913 0.0057 0.4609 0.0128 
  Leu_3 d [x234xx]+[x234xx] [x2].[x2x].[x2x]+[x2].[x2x].[x2x] 0.3825 0.0057 0.4050 0.0128 
  Leu_3 t [x234xx] [x2].[x2x].[x2x] 0.1262 0.0057 0.1340 0.0128 
OAA/PYR Ile_2 s [123xxx] [12xx].[x2x] 0.3112 0.0200 0.3043 0.0200 
  Ile_2 d1 [123xxx] [12xx].[x2x] 0.4506 0.0200 0.4318 0.0200 
  Ile_2 d2 [123xxx] [12xx].[x2x] 0.1059 0.0200 0.1859 0.0200 
  Ile_2 dd [123xxx] [12xx].[x2x] 0.1323 0.0200 0.0780 0.0200 
  Ile_3 s [x234xx] [x23x].[x2x] 0.0226 0.0103 0.0230 0.0176 
  Ile_3 d [x234xx]+[x234xx] [x23x].[x2x]+[x23x].[x2x] 0.7449 0.0103 0.6368 0.0176 
  Ile_3 t [x234xx] [x23x].[x2x] 0.2325 0.0103 0.3402 0.0176 
  Ile_4 s [xx345x] [xx34].[x2x] 0.3661 0.0129 0.3642 0.0126 
  Ile_4 d [xx345x]+[xx345x] [xx34].[x2x]+[xx34].[x2x] 0.4888 0.0129 0.4975 0.0126 
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  Ile_4 t [xx345x] [xx34].[x2x] 0.1451 0.0129 0.1383 0.0126 
  Lys_3 s [x234xx] 0.5{[x234]+[x23].[xxx4]} 0.1992 0.0045 0.2434 0.0698 
  Lys_3 d [x234xx]+[x234xx] 0.5{[x234]+[x23].[xxx4]+[x234]+[x23].[xxx4]} 0.5413 0.0045 0.5444 0.0698 
  Lys_3 t [x234xx] 0.5{[x234]+[x23].[xxx4]} 0.2595 0.0045 0.2123 0.0698 
  Lys_4 s [xx345x] [xx34].[xx3] 0.2224 0.0216 0.1936 0.0286 
  Lys_4 d [xx345x]+[xx345x] [xx34].[xx3]+[xx34].[xx3] 0.5338 0.0216 0.5407 0.0286 
  Lys_4 t [xx345x] [xx34].[xx3] 0.2437 0.0216 0.2657 0.0286 
  Lys_5 s [xxx456] 0.5{[x234]+[x23].[xxx4]} 0.2034 0.0073 0.2319 0.0200 
  Lys_5 d [xxx456]+[xxx456] 0.5{[x234]+[x23].[xxx4]+[x234]+[x23].[xxx4]} 0.5209 0.0073 0.5267 0.0200 
  Lys_5 t [xxx456] 0.5{[x234]+[x23].[xxx4]} 0.2757 0.0073 0.2414 0.0200 
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  7.8 Metabolic flux reaction network for central carbon metabolism for model 1 and model 2 
Table 13 metabolic pathways with stoichiometric reactions and enzyme information for model 1 
Reaction name Stoichiometry chemistry Atom transition Gene  Enzyme 
EMP Pathway (Glycolysis) 
pts Glu+PEP->G6P+PYR abcdef+ABC->abcdef+ABC manZ/b1819,ptsP/2829,manX/b1817,ptsH/b2415 ptsG,manZ,ptsH,pts 
pgi G6P -> F6P abcdef ->abcdef pgi/b4025 Pgi 
fba F6P->T3P+T3P abcdef ->cba+def fbaA/b2925, fbaB/b2097 fbaA,fbaB 
tpi T3P->G3P abc->abc tpiA/b3919 tpiA, 
pgk G3P->3PG abc->abc pgk/b2926 pgk 
eno 3PG->PEP abc->abc eno/b2779 eno 
pyk PEP-> PYR abc->abc pykF/b1676,pykA/b1854 pykF/pykA 
Entner Doudoroff Pathway 
eda 6PG->PYR+T3P abcdef -> abc+def eda/b1850 eda 
pentose phosphate pathway (PPPathway) 
zwf G6P->6PG abcdef ->abcdef zwf/b1852 zwf 
rpi 6PG->R5P+CO2 abcdef->bcdef+a gnd/b2029,rpe/b3386, rpiA/b2914,rpiB/b4090 gnd,rpe,rpiA,rpiB 
tkt R5P+R5P->S7P+T3P 
abcde+ABCDE-
>abABCDE+cde tktA/2935,tktB/b2465 tktA,tktB 
tktAB R5P+E4P->F6P+T3P abcde+ABCD->abABCD+cde tktA/2935,tktB/b2465 tktA,tktB 
talf S7P+T3P->F6P+E4P abcdefg+ABC->abcABC+defg talA/2464,talB/b0008 talA,talB 
TCA cycle 
mdh MAL->OAA abcd->abcd mqo/b2210,mdh/b3236 mqo,mdh 
frd SUCC->MAL abcd->abcd sdhA/b0723,sdhB/b0724,sdhC/b0721,sdhD/0722 
sdhA,sdhB,sdhC,sd
hD 
icd 
ACCOA+OAA-
>AKG+CO2 ab+ABCD->DCBba+A icdB/b0720,icd/b1136 icdB,icd 
suc AKG->SUCC+CO2 abcde->bcde+a lpd/b0116, sucA/b0726,sucB/b0727 lpd,sucA,sucB 
acetyl-CoA biosynthesis (from pyruvate) and fermentative pathway 
ace PYR->ACCOA+CO2 abc->bc+a lpd/b0116,aceF/b0115,aceE/b0114 lpd,aceF,aceE 
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pox PYR->AC+CO2 abc->bc+a poxB/ b0871 poxB 
ackf ACCOA->AC ab->ab pta/b2297, ackA/b2296,acs/b4069 pta,ackA,acs 
anaplerotic pathway 
ppc PEP+CO2->OAA abc+A->abcA ppc/b3956 ppc 
aceA 
ACCOA+OAA-
>GOx+SUCC ab+ABCD->DC+ABba aceA/b4015 aceA 
aceB ACCOA+GOX-> MAL ab+AB->Abba aceB/b4014 aceB 
ana Mal->PYR+CO2 abcd->abc+d maeA/b1479, maeB/b2463 maeA 
C1 metabolism 
ser 3PG->Ser abc->abc serA/b2913,serC/b0907, serB/b4388 serA,serC,serB 
gly Ser->Gly+C1 abc->ab+c glyA/b2551 glyA 
Transport pathway 
ac AC->ACout 
  
  
co2 CO2 ->CO2out       
biomass synthesis pathway 
G6pb G6P -> biomass 
  
  
R5pb R5P -> biomass 
  
  
E4pb E4P ->biomass 
  
  
T3pb T3P ->biomass 
  
  
PEPb PEP ->biomass 
  
  
PYRb PYR ->biomass 
  
  
ACCOAb ACCOA ->biomass 
 
  
AKGb AKG -> biomass 
  
  
OAAb OAA -> biomass 
  
  
3PGb 3PG -> biomass 
  
  
F6Pb F6P ->biomass 
  
  
C1b C1 ->biomass 
  
  
serb Ser ->biomass 
  
  
glyb Gly ->biomass 
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Table 14 metabolic pathways with stoichiometric reactions and enzyme information for model 2  
Reaction 
name Stoichiometry chemistry Atom transition Gene  Enzyme 
EMP Pathway (Glycolysis) 
pts Glu+PEP->G6P+PYR abcdef+ABC->abcdef+ABC manZ/b1819,ptsP/2829,manX/b1817,ptsH/b2415 
ptsG,manZ,pt
sH,ptsP 
pgi G6P -> F6P abcdef ->abcdef pgi/b4025 Pgi 
fbp F6P ->FBP abcdef ->abcdef pfkA/b3916,pfkB/b1723                                               pfkA,pfkB 
fba FBP->T3P+T3P abcdef ->cba+def fbaA/b2925, fbaB/b2097 fbaA,fbaB 
tpi T3P->G3P abc->abc tpiA/b3919 tpiA, 
pgk G3P->3PG abc->abc pgk/b2926 pgk 
eno 3PG->PEP abc->abc eno/b2779 eno 
pyk PEP-> PYR abc->abc pykF/b1676,pykA/b1854 pykF/pykA 
Entner Doudoroff Pathway 
eda 6PG->PYR+T3P abcdef -> abc+def eda/b1850 eda 
pentose phosphate pathway (PPPathway) 
zwf  G6P->6PG abcdef ->abcdef zwf/b1852 zwf 
rpi 6PG->R5P+CO2 abcdef->bcdef+a gnd/b2029,rpe/b3386, rpiA/b2914,rpiB/b4090 
gnd,rpe,rpiA,
rpiB 
tkt R5P+R5P->S7P+T3P abcde+ABCDE->abABCDE+cde tktA/2935,tktB/b2465 tktA,tktB 
tktAB R5P+E4P->F6P+T3P abcde+ABCD->abABCD+cde tktA/2935,tktB/b2465 tktA,tktB 
talf S7P+T3P->F6P+E4P abcdefg+ABC->abcABC+defg talA/2464,talB/b0008 talA,talB 
TCA cycle 
mdh MAL->OAA abcd->abcd mqo/b2210,mdh/b3236 mqo,mdh 
frd SUCC->FUM abcd->abcd sdhA/b0723,sdhB/b0724,sdhC/b0721,sdhD/0722 
sdhA,sdhB,sd
hC,sdhD 
succ FUM->MAL abcd->abcd fumA/b1612,fumB/b4122,fumC/b1611 
fumA,fumB,f
umC 
icd ACCOA+OAA->AKG+CO2 ab+ABCD->DCBba+A icdB/b0720,icd/b1136 icdB,icd 
suc AKG->SUCC+CO2 abcde->bcde+a lpd/b0116, sucA/b0726,sucB/b0727 
lpd,sucA,suc
B 
acetyl-CoA biosynthesis (from pyruvate) and fermentative pathway 
ace PYR->ACCOA+CO2 abc->bc+a lpd/b0116,aceF/b0115,aceE/b0114 lpd,aceF,aceE 
pox PYR->AC+CO2 abc->bc+a poxB/ b0871 poxB 
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ackf ACCOA->AC ab->ab pta/b2297, ackA/b2296,acs/b4069 pta,ackA,acs 
anaplerotic pathway 
ppc PEP+CO2->OAA abc+A->abcA ppc/b3956 ppc 
aceA ACCOA+OAA->GOx+SUCC ab+ABCD->DC+ABba aceA/b4015 aceA 
aceB ACCOA+GOX-> MAL ab+AB->Abba aceB/b4014 aceB 
ana Mal->PYR+CO2 abcd->abc+d maeA/b1479, maeB/b2463 maeA 
C1 metabolism 
ser 3PG->Ser abc->abc serA/b2913,serC/b0907, serB/b4388 
serA,serC,ser
B 
gly Ser->Gly+C1 abc->ab+c glyA/b2551 glyA 
amino acid biosynthesis and metabolic pathway 
SdaRf Ser->PYR abc->abc sdaA/b1814,sdaB/b2797,tdcG/b4471,tdcB/b3117 
sdaA,sdaB,td
cB,tdcG 
thr OAA->Thr abcd->abcd thrC/b0004 thrC 
thrgly Thr->Gly+ACCOA abcd->ab+cd ItaE/b0870 ItaE 
GluDy Glut->AKG abcde->abcde gdhA/b1761 gdhA 
GlnDy Glut->Gln abcde->abcde glnA/b3870 glnA 
GLUSy AKG+Gln->Glut+Glut abcde+ABCDE->abcde+ABCDE gltB/b3212, gltD/b3213 gltB,gltD 
ALATA AKG+Ala->Glut+PYR abcde+ABC->abcde+ABC alaA/b2290,alaB/ G0-9281(Ecocyc), alaC/b2379 
alaA,alaB,ala
C 
ASPTA AKG+Asp->Glut+OAA abcde+ABC->abcde+ABC aspC/b0928 aspC 
Ala PYR->Ala abc->abc dadA/b1189 dadA 
Asp OAA->Asp abcd->abcd aspC/b0928 aspC 
Arg Glut->Arg abcde->abcde argH/b3960 argH 
Pro Glut->Pro abcde->abcde proC/b0386 proC 
Transport pathway 
ac AC->ACout       
co2 CO2 ->CO2out       
biomass synthesis pathway 
G6pb G6P -> biomass       
R5pb R5P -> biomass 
  
  
E4pb E4P ->biomass 
  
  
T3pb T3P ->biomass 
  
  
PEPb PEP ->biomass 
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PYRb PYR ->biomass 
  
  
ACCOAb ACCOA ->biomass 
  
  
AKGb AKG -> biomass 
  
  
OAAb OAA -> biomass 
  
  
3PGb 3PG -> biomass 
  
  
F6Pb F6P ->biomass 
  
  
C1b C1 ->biomass 
  
  
serb Ser ->biomass 
  
  
glyb Gly ->biomass 
  
  
thrb Thr ->biomass 
  
  
glutb Glut ->biomass 
  
  
glunb Glu ->biomass 
  
  
alab Ala ->biomass 
  
  
aspb Asp->biomass 
  
  
argb Arg -> biomass 
  
  
prob Pro ->biomass       
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  7.9 Simulation results for average result from three biological replicate 
for both Model 1 and Model2 
Table 15 Normalized flux value for control and 35 mM C8 in metabolic Model 1, data shown are from three 
replicates with 200 runs in NMR2Flux 
 
Control C8 
 
AVG SD AVG SD 
In 100.00 0.00 100.00 0.00 
pts 100.00 0.00 100.00 0.00 
pgif 89.10 1.57 88.95 3.52 
pgib 0.08 0.00 0.52 0.22 
fba 90.30 0.63 88.17 3.80 
tpif 180.18 0.63 179.64 3.80 
tpib 0.49 0.01 0.50 0.01 
pgk 180.18 0.63 179.64 3.80 
eno 173.12 0.63 173.67 3.80 
ser 3.83 0.00 3.24 0.00 
gly 3.54 0.00 2.99 0.00 
pyk 25.02 6.60 42.43 5.22 
zwf 9.65 1.57 10.00 3.52 
rpi 9.00 1.42 4.91 0.99 
eda 0.65 0.17 5.09 3.97 
tktf 1.91 0.47 0.72 0.33 
tktb 0.67 0.32 0.90 0.11 
tktABf -0.29 0.47 -1.13 0.33 
tktABb 0.93 0.01 0.96 0.01 
talf 1.91 0.47 0.72 0.33 
talb 0.22 0.24 0.89 0.12 
ppcf 44.94 6.92 28.57 3.50 
ppcb 0.27 0.15 0.10 0.01 
mqof 22.09 6.74 27.83 12.99 
mqob 0.87 0.10 0.80 0.17 
frdb 49.59 0.51 41.69 9.66 
frdf 0.93 0.02 0.95 0.02 
frds 0.74 0.04 0.80 0.06 
ace 100.12 2.69 91.31 4.48 
pox 38.54 2.49 59.00 3.09 
ackf 20.91 2.52 23.43 9.13 
ackb 0.47 0.01 0.48 0.03 
icd 55.89 0.35 45.83 7.67 
suc 49.33 0.35 40.29 7.67 
aceA 0.27 0.18 1.40 2.00 
aceB 0.27 0.18 1.40 2.00 
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ana 27.77 7.05 15.26 1.95 
ac 59.45 0.05 82.43 9.33 
co2 235.71 0.09 228.02 18.67 
g6p 1.25 0.00 1.05 0.00 
f6p 0.43 0.00 0.36 0.00 
r5p 5.46 0.00 4.61 0.00 
e4p 2.20 0.00 1.85 0.00 
t3p 0.78 0.00 0.66 0.00 
pep 3.16 0.00 2.67 0.00 
pyr 14.78 0.00 12.48 0.00 
accoa 22.79 0.00 19.24 0.00 
akg 6.56 0.00 5.54 0.00 
oaa 10.87 0.00 9.17 0.00 
3pg 3.23 0.00 2.73 0.00 
serb 0.29 0.00 0.25 0.00 
c1out 3.54 0.00 2.99 0.00 
glyb 3.54 0.00 2.99 0.00 
 
Table 16 Normalized flux value for control and 35 mM C8 in metabolic Model 2, data shown are from three 
replicates with 200 runs in NMR2Flux 
 
Control C8 stress 
 
Average SD Average SD 
In 100.00 0.00 100.00 0.00 
pts 100.00 0.00 100.00 0.00 
pgif 93.90 1.51 93.41 2.07 
pgib 0.06 0.03 0.02 0.01 
fbp 91.50 1.53 91.61 1.72 
fbpb 0.61 0.14 0.56 0.58 
fba 91.50 1.53 91.61 1.72 
fbab 0.51 0.13 0.49 0.66 
tpif 182.00 1.45 183.16 2.37 
tpib 0.97 0.01 0.83 0.23 
pgkf 182.00 1.45 183.16 2.37 
pgkb 0.98 0.01 0.95 0.06 
eno 171.63 1.55 173.83 2.40 
enob 0.05 0.04 0.68 0.26 
pyk 1.69 2.01 45.70 1.50 
pykb 0.73 0.16 0.24 0.06 
zwf 4.83 1.50 5.45 2.07 
rpi 2.92 0.14 3.07 1.22 
eda 1.91 1.63 2.37 0.86 
tktf 0.12 0.00 0.27 0.17 
tktb 0.83 0.17 0.95 0.02 
tktABf -2.10 0.02 -1.72 0.20 
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tktABb 0.32 0.21 0.91 0.03 
talf 0.12 0.00 0.27 0.17 
talb 0.34 0.04 0.76 0.28 
ppcf 66.72 1.79 25.25 0.89 
ppcb 0.25 0.10 0.04 0.01 
mqof 15.87 1.85 24.66 0.55 
mqob 0.99 0.00 0.86 0.06 
frdf 62.07 0.07 33.01 1.05 
frdb 0.29 0.06 0.76 0.22 
frds 0.07 0.03 0.61 0.32 
succf 62.07 0.07 33.01 1.05 
succb 0.93 0.04 0.76 0.17 
succs 0.39 0.07 0.60 0.16 
ace 139.56 0.00 60.18 1.18 
pox 0.00 0.08 88.11 2.67 
ackf 50.00 0.00 1.89 2.67 
ackb 0.97 0.02 0.35 0.44 
icd 68.69 0.07 38.18 0.68 
suc 61.97 0.07 32.24 0.65 
aceA 0.10 0.01 0.76 0.40 
aceB 0.10 0.01 0.76 0.40 
ana 46.31 1.79 9.11 0.89 
serf 7.16 0.13 6.45 0.04 
glyf 0.28 0.00 0.26 0.01 
glyb 0.92 0.01 0.99 0.00 
sdaRf 4.81 0.13 4.33 0.05 
sdaRb 0.01 0.00 0.83 0.10 
thrf 4.17 0.02 3.10 0.07 
thrglyf 2.70 0.00 2.11 0.07 
thrglyb 0.12 0.11 0.22 0.31 
GLUDy -0.16 0.43 1.71 0.50 
GLUDyb 0.20 0.08 0.00 0.00 
GlnDy 4.78 0.12 4.11 0.54 
GlnDyb 0.81 0.06 0.99 0.00 
GLUSy 3.22 0.12 2.72 0.54 
GLUSyb 0.94 0.02 0.17 0.02 
ALATA 0.15 0.08 0.57 0.02 
ALATAb 0.00 0.00 0.19 0.06 
ASPTA1 2.97 0.32 0.51 0.05 
ASPTA1b 0.62 0.02 0.00 0.00 
Alab 0.10 0.03 0.65 0.22 
Alaf 3.19 0.08 3.05 0.09 
ASPf 4.38 0.31 1.45 0.02 
ASPb 0.47 0.02 0.47 0.03 
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argf 1.75 0.00 1.56 0.00 
argb 0.50 0.03 0.53 0.05 
prof 1.31 0.00 1.17 0.00 
prob 0.46 0.04 0.49 0.04 
ac 50.00 0.00 90.00 0.00 
co2 252.73 0.16 205.64 1.61 
g6p 1.27 0.01 1.14 0.00 
r5p 4.78 0.12 4.25 0.68 
e4p 2.23 0.02 1.99 0.03 
t3p 0.80 0.01 0.72 0.00 
pep 3.23 0.02 2.87 0.01 
pyr 12.11 0.00 10.74 0.03 
accoa 23.36 0.00 20.69 0.09 
akg 0.55 0.00 0.42 0.02 
oaa 8.20 0.01 6.93 0.26 
3pg 3.21 0.10 2.88 0.07 
f6p 0.42 0.01 0.36 0.01 
C1 0.28 0.00 0.26 0.01 
serb 2.07 0.01 1.86 0.00 
glyb 2.98 0.00 2.36 0.06 
thrb 1.47 0.03 0.99 0.01 
glut 1.56 0.00 1.39 0.00 
glun 1.56 0.00 1.39 0.00 
Alab 3.04 0.00 2.49 0.06 
Aspb 1.42 0.02 0.95 0.03 
argbout 1.75 0.00 1.56 0.00 
probout 1.31 0.00 1.17 0.00 
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